Holdings: Abnormal psychology

Abnormal psychology:

Saved in:

Bibliographic Details
Format:	Book
Language:	English
Published:	Hoboken, NJ Wiley 2010
Edition:	11. ed., internat. student version
Subjects:	Psychopathologie Psychology, Pathological Psychopathology Mental Disorders Psychische Störung Einführung Handboeken (vorm)
Online Access:	Publisher description Table of contents only Inhaltsverzeichnis
Physical Description:	XXI, 545 S., getr. Zählung Ill., graph. Darst., Kt. 29 cm
ISBN:	9780470413340

Staff View

MARC


LEADER	00000nam a2200000zc 4500
001	BV021832727
003	DE-604
005	20100201
007	t
008	061129s2010 xxuabd\| \|\|\|\| 00\|\|\| eng d
010			\|a 2005056738
020			\|a 9780470413340 \|c alk. paper \|9 978-0-470-41334-0
035			\|a (OCoLC)428065851
035			\|a (DE-599)BVBBV021832727
040			\|a DE-604 \|b ger \|e aacr
041	0		\|a eng
044			\|a xxu \|c US
049			\|a DE-473 \|a DE-355 \|a DE-11
050		0	\|a RC454
082	0		\|a 616.89
084			\|a CU 1000 \|0 (DE-625)19079: \|2 rvk
084			\|a CU 3000 \|0 (DE-625)19104: \|2 rvk
245	1	0	\|a Abnormal psychology \|c Ann M. Kring ...
250			\|a 11. ed., internat. student version
264		1	\|a Hoboken, NJ \|b Wiley \|c 2010
300			\|a XXI, 545 S., getr. Zählung \|b Ill., graph. Darst., Kt. \|c 29 cm
336			\|b txt \|2 rdacontent
337			\|b n \|2 rdamedia
338			\|b nc \|2 rdacarrier
650		7	\|a Psychopathologie \|2 gtt
650		4	\|a Psychology, Pathological
650		4	\|a Psychopathology
650		4	\|a Mental Disorders
650	0	7	\|a Psychische Störung \|0 (DE-588)4047686-8 \|2 gnd \|9 rswk-swf
655		7	\|0 (DE-588)4151278-9 \|a Einführung \|2 gnd-content
655		7	\|a Handboeken (vorm) \|2 gtt
689	0	0	\|a Psychische Störung \|0 (DE-588)4047686-8 \|D s
689	0		\|C b \|5 DE-604
700	1		\|a Kring, Ann M. \|d 19XX- \|e Sonstige \|0 (DE-588)102812855X \|4 oth
856	4		\|u http://www.loc.gov/catdir/enhancements/fy0645/2005056738-d.html \|3 Publisher description
856	4		\|u http://www.loc.gov/catdir/enhancements/fy0645/2005056738-t.html \|3 Table of contents only
856	4	2	\|m Digitalisierung UB Bamberg \|q application/pdf \|u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015044696&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA \|3 Inhaltsverzeichnis
999			\|a oai:aleph.bib-bvb.de:BVB01-015044696

Record in the Search Index

_version_	1804135763574521856
adam_text	Subject Index ABAB design, 114 Acamprosate, 310 Accidents, childhood, 448 Acetylcholinesterase inhibitors, 471 Acquired immunodeficiency syndrome (AIDS), 200-203 clinical description of, 201 disease spreading and, 201 intravenous drug use and, 291 prevention efforts and, 201-203 scope of, 200-201 Acute stress disorder (ASD), 127, 151 Addiction. See Substance-related disorders Addington v. Texas (1979), 533 Adolescent anxiety. See Childhood and adolescent anxiety Adolescent depression. See Childhood and adolescent depression Advanced directives, patient rights and, 538 Advocacy groups, 5 African-Americans, therapeutic considerations and, 508-511 Age. See also specific age group arrest rates and, 427 depressive disorders and, 218-219 dissociative identity disorders and, 166-167 mental retardation and, 445 research methods in study of, 465 Agonists, 36 Agoraphobia cognitive factors in, 139 criteria for, 124 fear-of-fear hypothesis and, 139 psychological treatment of, 147-148 AIDS. See Acquired immunodeficiency syndrome Alaskan Natives, therapeutic considerations and, 511 Alcohol abuse and dependence, 280-283 Alcoholics Anonymous and, 306-307 behavioral treatments and, 307-308 cognitive treatments and, 307-308 couples therapy and, 307 cultural attitudes and, 302-303 delirium tremens and, 280 detoxification and, 305-306 expectancies about, 301-302 fetal alcohol syndrome and, 283 genetic factors and, 296 inpatient hospital treatment and, 305-306 late life and, 483 long-term alcohol effects, 282-283 medications and, 309-310 moderation in drinking and, 309 polydrug abuse and, 280 prevalence and cost of, 281 relapse prevention and, 308 short-term alcohol effects, 282 stress and, 300 treatment of, 305-310 Alcoholics Anonymous (AA), 306-307 Alíeles, 31 Allostatic load, stress hormones and, 189 Alogia, schizophrenia and, 323 Alternate-form reliability, 60 Alternative living settings, older adults and, 487-488 Altruistic suicide, 249 Alzheimer s disease, 108-109, 468-470 Ambulatory monitoring studies, hypertension and, 193-194 Amenorrhea, anorexia nervosa and, 254 American Association on Intellectual and Development Disabilities (AAIDD), 445-447 American Indians, therapeutic considerations and, 511 American Law Institute Guidelines, 521 American Legacy Foundation, 317 Americans with Disabilities Act (ADA), 4, 351 Amok, 67 Amphetamine psychosis, 332 Amphetamines, 291-293 Amygdala, 37, 226-227 Anal stage, psychosexual development and, 19 Analogue experiments, 113-114 Analytical psychology, 20 Anesthesia, conversion disorder and, 173 Angel dust, 296 Anger coronary heart disease and, 197 hypertension and, 194, 209 reducing, 209 Anger-in theory, 191 Angina pectoris, 195 Anhedonia, 323 Anomie suicide, 249 Anorexia nervosa clinical description of, 254-256 cognitive behavioral views and, 264-265 cross-cultural studies and, 268-269 genetic factors, 261-262 medications and, 273 neurobiological factors and, 262-263 perfectionism and, 270 personality influences and, 270-271 physical consequences of, 256 prognosis and, 256 psychodynamic views and, 263-264 psychological treatment of, 273 sociocultural factors and, 266-270 treatment of, 272-276 types of, 254-255 Anosmia, 173 Antabuse, 309 Antagonists, 36 Anterior cingulate, 37, 140 Anticipatory pleasure, schizophrenia and, 323 Anticonvulsant medications bipolar disorder and, 244 depression and, 241 Antidepressant medications anxiety disorders and, 152 bipolar disorder and, 244 childhood and adolescent depression and, 434, 436 depressive disorders and, 241-243 eating disorders and, 272 older adults and, 480-481 Antiobesity medications, 273 Antipsychotic medications bipolar disorder and, 244 depression and, 241 first-generation, 342-344 second-generation, 344-345 Antisocial acts, psychopathy and, 369-370 Antisocial personality disorder, 367-371 clinical description and, 368 etiology of, 368-371 family environment and, 369 genetic factors and, 369 social factors and, 369 Anxiety disorders. See also Childhood and adolescent anxiety; Phobias actual threats and, 132 affective dimensions in, 232 attention to threat and, 133 behavioral inhibition and, 132 characteristics of, 120 clinical descriptions of, 121-127 cognitive factors and, 132-133 common risk factors and, 130-134 commonalties across psychological treatments, 146 comorbidity in, 128 conduct disorder and, 427 critical incident stress debriefing and, 151 defense mechanisms and, 131 etiology of, 134-145 eye movement desensitization and reprocessing and, 150 fear circuit and, 131 S2 Subject Index Anxiety disorders (cont.) gender and, 128-129 genetic factors and, 131 late life, 481-482 medications and, 152-153 negative cognition and, 133-134 neurobiological factors and, 131-132 neuroticism and, 132 perceived control and, 133 personality and, 132 phobias, 121-123 psychoanalytic perspective and, 131 safety behaviors and, 132-133 social environment and, 132 sociocultural factors and, 129-130 treatment of, 145-153 Anxiety reduction, sexual dysfunctions and, 392-394 Anxiety Sensitivity Index, 139 Anxiolytics, 152 Anxious/fearful cluster, personality disorders and, 372-374 Apathy, 323 Aphonia, 173 Aricept, 471 Arousal, post-traumatic stress disorder and, 127 Articulated Thoughts in Simulated Situations (ATSS), 87 Asian-Americans, therapeutic considerations and, 508-511 Asociality, schizophrenia and, 324 Asperger s disorder, 451 Assessment of Daily Experience (ADE) scale, 78-79, 185-186 Assisted-living facilities, 487-488 Assisted outpatient treatment, 4 Association studies, molecular genetics and, 109 Asthma, 197-200 biological factors and, 199 clinical description of, 198-199 etiology of, 199-200 negative emotions and, 199-200 respiratory structures and, 198 role of family and, 200 stressful life events and, 199 Asylums, 11-13 Ataque de nervios, 129 Attachment theory, 42 Attention-deficit/hyperactivity disorder (ADHD), 418-428 adolescent behavior and, 422 adults with, 421-422 clinical descriptions of, 418-420 cultural role and, 419 differential diagnosis and, 420 environmental toxins and, 423 etiology of, 422-424 genetic factors and, 422 neurobiological factors and, 422-423 perinatal and prenatal factors and, 423 prevalence of, 421 psychological factors and, 423-424 psychological treatment and, 425-426 stimulant medications and, 424-425 subcategories of, 420 treatment of, 424-426 Attributional style, 235 Attributional Style Questionnaire (ASQ), 235-236 Attributions, depression and, 235 Autistic disorder, 450-459 Asperger s disorder and, 451 behavioral treatment and, 458 clinical descriptions and, 451-455 communication deficits and, 453-454 diagnosis and causes of, 437 drug treatment and, 459 echolalia and, 453 etiology of, 455-457 genetic factors and, 455 high-functioning and, 453, 456 joint attention and, 452 mental retardation and, 451-452 neurological factors and, 455-457 play and, 453 prognosis and, 454-455 pronoun reversal and, 454 repetitive and ritualistic acts and, 454 social and emotional disturbances and, 452-453 theory of mind and, 453 treatment of, 457-459 Autonomie nervous system, 38, 39, 429 Aversion therapy, paraphilias and, 409-410 Aversive conditioning, 24 Avoidance, post-traumatic stress disorder and, 127 Avoidance coping, 186 Avoidant personality disorder, 123, 372 Avolition, schizophrenia and, 323 Awakenings, 325 В Barbiturates, 291 Bedford College Life Events and Difficulties (LEDS), 78-79, 82 Behavior genetics, 30-31. See also Genetics adoptees method and, 108 family method and, 107 genotypes and, 30 index cases and, 107 IQ and, 31 phenotypes and, 30-31 schizophrenia and, 328-330 twin method and, 108 Behavioral and cognitive assessment, 85-87 capturing thought through specific situation, 87 cognitive-style questionnaires, 86 direct observation, 85 self-observation, 85-86 Behavioral factors/therapies, 493-494 alcohol abuse and, 307-308 anxiety disorders and, 132 autism and, 458 behavioral activation therapy, 493-494 couples therapy, 497 depression and, 238-240 gender identity disorder and, 399 historical overview of, 24 influences from, 44-46 mental retardation and, 449 panic disorder and, 138 post-traumatic stress disorder and, 143 self-control and, 494 skills training, 211 somatoform disorders and, 179 specific phobias and, 135-136 Behavioral medicine field, 184 Behaviorism, 22 Benzedrine, 291 Benzodiazepines, 152 Beta blockers, 152 Bing-eating/purging type of anorexia nervosa, 254-255 Binge drinking, 281 Biological approaches, 14-16. See also Neurobiological assessment electroconvulsive therapy, 15 general paresis and syphilis and, 14-15 genetics and, 15 mood disorders and, 241-244 paraphilias and, 410 prefrontal lobotomy 15-16 psychological approaches, 16-24 Biological factors asthma and, 199 sexual dysfunctions and, 390 Bipolar disorders, 219-221. See also Mood disorders bipolar I disorder, 220 bipolar II disorder, 220 brain-imaging studies and, 226-228 case studies and, 102-103 in children, 436 consequences of, 221 cyclothymic disorder, 220 depression in, 236 epidemiology of, 220-221 family-focused treatment and, 240 flight of ideas and, 219 genetic factors and, 223-224 hypomania and, 220 mania and, 219, 236 medications for, 244 mixed episodes and, 219-220 neurobiological factors and, 223-229 neurotransmitters and, 224-226 psychoeducational approaches and, 240 psychological factors and, 236 psychological treatment of, 240 social factors and, 236 subtypes and, 222 Bipolar I disorder, 220 Bipolar II disorder, 220 Black box warnings, 436-437 Blindness. See also Conversion disorder Blindsight, 175 Blood alcohol concentration calculator, 282 Blood pressure. See also Essential hypertension Body dysmorphic disorder anorexia nervosa and, 254 criteria for, 170 eating disorders and, 267 neurobiology of, 177 treatment of, 179 Body mass index (BMI), 258 BOLD signal, fMRI, 89 Borderline personality disorder, 362-365 childhood abuse and, 364 clinical description of, 362-363 dialectical behavior therapy and, 377-378 diathesis-stress theory and, 364365 etiology of, 363-365 Subject Index S3 neurobiological factors and, 363-364 object relations psychotherapy and, 377 object relations theory and, 364 psychotherapy efficacy and, 378-379 schema-schema-focused cognitive therapy and, 378 social factors and, 364 treatment of, 376-379 Brain. See Neurobiological assessment/factors Brain imaging, 89-90, 226-228 Brain stem, 37 Brain structure and function, 36-38 Breast self-examination, 210-211 Brief psychotic disorder, 327 Brief therapy, psychodynamic, 43 Briquets syndrome, 171 Bulimia nervosa clinical description of, 256-258 cognitive behavioral views and, 265-266 cross-cultural studies and, 369 genetic factors, 261-262 medications and, 272-273 neurobiological factors and, 262-263 personality influences and, 270-271 physical consequences of, 258 prognosis and, 258 psychodynamic views and, 263-264 psychological treatment and, 274-275 sociocultural factors and, 266-270 subtypes of, 257 treatment of, 272-276 Buprenorphine, 315 Bupropion, 395 С Caffeine, 292 Cancer coping with, 210-211 ethnicity and, 207 interventions and, 210 problem-solving therapy and, 210 Capital punishment issues, 527-530 Cardiovascular disorders coronary heart disease, 195-197 depression and, 479 essential hypertension and, 192-195 ethnicity and, 207 Caregiver support, dementia and, 473 Carpal tunnel syndrome, 174 Case studies, 100-103 advantages and disadvantages of, 102 characteristics of, 100-101 hypotheses and, 101 as rich description, 101 Castration, 410 Castration anxiety 407 Catastrophic misinterpretation, 130 Catatonia catatonic immobility, 325 mood disorders and, 222 schizophrenia and, 325, 327 Categorical classification, 70-71 Cathartic method, 17 Causality problems, correlational method and, 105 Celexa, 242 Cerebellum, 37, 337 Cerebral blood flow, schizophrenia and, 336 Change research, psychotherapy process and, 513-514 Chaos theory, 99 Child abuse. See also Sexual abuse borderline personality disorder and, 364 dissociative identity disorder and, 163 eating disorders and, 271 memory repression and, 158-159 paraphilias and, 408 pedophilia and incest, 402-405 Childhood and adolescent anxiety, 438-441 clinical descriptions of, 438-439 cognitive behavior therapy and, 440-441 obsessive compulsive disorder and, 439 prevalence of, 439 school phobia and, 439 social phobia and, 439 treatment of, 440-441 Childhood and adolescent depression, 433-438 antidepressants and, 434 clinical descriptions of, 433 cognitive behavioral treatments and, 435 etiology of, 434-435 prevalence of, 433 prevention and, 438 psychosocial interventions and, 435 psychotherapy and, 438 treatment controversies and, 436-437 treatment of, 434-438 Childhood disorders antidepressant medications controversies, 436 anxiety and, 438-441 attention-deficit/hyperactivity disorder, 418-428 autistic disorder, 437, 450-459 bipolar disorder controversies, 436 classification of, 418 conduct disorder, 426-432 controversies in diagnosis and treatment, 436-437 depression and, 433-438 diagnosis of, 418 externalizing disorders and, 418 internalizing disorders and, 418 learning disabilities, 441-444 mental retardation, 444-450 stimulant medication controversies, 436-437 Chromosomal abnormalities, mental retardation and, 447 Cialis, 395 Cigarette smoking, 284-285. See also Nicotine advertising and media and, 304 prevalence and health consequences of, 284 secondhand smoke and, 284-285 Citalopram, 242 Civil commitment, 530-540 advanced directives and, 538 deinstutionalization and, 538-540 least restrictive alternative and, 533-534 outpatient commitment, 532-533 patient s rights protection and, 533-538 prediction of dangerousness and, 532-533 preventative detention and, 531-533 privileged communication and, 534-535 right to refuse treatment, 537-538 right to treatment and, 534-537 Classical conditioning historical overview and, 22 panic disorder and, 138 specific phobias and, 135 Cleanliness, compulsions and, 125 Client-centered therapy, 491-492 Clinical interviews, 74-76 characteristics of, 75 structured interviews, 75-76 Clinical psychologists, 25 Clinical significance, correlational method and, 104-105 Clozapine, 344-345 Cocaine, 293-294, 300, 313, 315 Cocaine vaccine, 315 Cognition distortions, paraphilias and, 408 Cognitive behavior therapy, 47-48. See also Cognitive treatments anorexia nervosa and, 273 Beck s cognitive therapy, 47 bulimia nervosa and, 274-275 childhood and adolescent anxiety and, 440-441 childhood and adolescent depression and, 435 couples and, 497 eating disorders and, 264-266 Ellis s rational-emotive behavior therapy, 47-48 illicit drag abuse and, 312-313 interventions, 212 outcome studies and, 506 paraphilias and, 409-410 personality disorders and, 375-376 schizophrenia and, 349-350 somatoform disorders and, 177-178 Cognitive behavioral paradigm behavior therapy influences, 44-46 cognitive behavior therapy, 47-48 cognitive science, 46-47 evaluating, 48 psychodynamic paradigm compared, 48 Cognitive biases, depression and, 233 Cognitive disorders, late life, 467-475 Cognitive enhancement therapy, 349-350 Cognitive factors. See also Social- cognitive perspective agoraphobia and, 130 anxiety disorders and, 132-133 depression and, 233-236 generalized anxiety disorder and, 140 obsessive-compulsive disorder and, 141-142 panic disorder and, 138-139 social phobias and, 137 stress and, 191 Cognitive functioning late life and, 463-464 marijuana use and, 286 S4 Subject Index Cognitive restructuring, 47, 211 Cognitive science, 46-47 Cognitive-style questionnaires, 86 Cognitive treatments, 494-495. See also Cognitive behavior therapy; Social-cognitive perspective alcohol abuse and, 307-308 depression and, 238-239 mental retardation and, 449 somatoform disorders and, 179 Cohort effects, research studies and, 465 Collective unconscious, 20 Common factors research, 512-513 Communication deficits, autistic disorder and, 453-454 Communication deviance, 338 Communication training, sexual dysfunctions and, 394 Community psychology, 514-515 Community-reinforcement approach, 307 Competency to stand trial, 524-527 Compulsions, 125 Computer-assisted instruction, mental retardation and, 449-450 Computerized axial tomography (CT scan), 89 Concordance, 108 Concurrent validity, 60 Conditioned response, 22 Conditioned stimulus, 22 Conditioning social phobias and, 136-137 specific phobias and, 135-136 Conduct disorder, 426-432 autonomie nervous system and, 429 clinical description and, 427 Dodge s aggression theory and, 430 etiology of, 428-430 family interventions and, 430-431 genetic factors and, 428-429 life-course-persistent type, 427-428 modeling and, 429 multisystemic treatment and, 432 neuropsychological factors and, 429 peer influences and, 430 prevalence of, 427 prognosis and, 426-427 psychological factors and, 429-430 social-cognitive perspective and, 429-430 sociocultural factors and, 430 treatment of, 430-432 Confidentiality, 543 Congenital factors, schizophrenia and, 336-337 Consensus Project, 540 Construct validity, 61, 72 Consummatory pleasure, 323 Contemporary psychodynamic perspectives, 43-44 Contemporary thought, 14-19 Content validity, 60 Contingency management therapy, 307 Continuing care retirement communities, 488 Control groups, 111 Controlled drinking, 309 Conversion disorder, 173-177 anesthesia and, 173 blindsight and, 175 cultural factors and, 175-176 description of, 168 diagnostic rates and, 176-177 etiology of, 174-177 psychodynamic perspective and, 175 social factors and, 175-176 symptoms of, 173-174 treatment of, 181 Coping avoidance copying, 186 emotion-focused, 186 health and, 186-187 problem-focused, 186 Coping Orientations to Problems Experienced Scale (COPE), 186-187 Coronary Artery Risk Development in Young Adults Study (CARDIA), 194 Coronary heart disease angina pectoris, 195 clinical description of, 195 etiology of, 195-196 gender and, 205 metabolic syndrome and, 195 myocardial infarction and, 195 psychological risk factors and, 196-197 stress and myocardial infarction, 196 Corpus callosum, 36 Correlation coefficient, 104 Correlational method, 101-109 behavior and molecular genetics example, 107-109 causality problems and, 105 clinical significance and, 104-105 correlation coefficient, 104 cross-sectional design and, 105 differences from experimental research, 101-103 directionality problem and, 105 epidemiological research example, 106-107 examples of, 103-104 high-risk method and, 106 longitudinal design and, 105 measuring correlation, 104 scatter diagrams and, 105 statistical significance and, 104 third-variable problems and, 106 Cortisol depression and, 228-229 post-traumatic stress disorder and, 143 release of, 38 Counseling psychologists, 26 Couples therapy, 495-496 alcohol abuse and, 307 depression and, 240 outcome studies and, 506-507 sexual dysfunctions and, 394 Crack, 293-294 Creativity, mood disorders and, 221 Criminal commitment, 518-530 in absentia trials and, 525 capital punishment issues, 527-530 competency to stand trial and, 524-527 dissociative identity disorder and, 528 insanity defense and, 519-524 mental retardation and, 530 synthetic sanity concept and, 527 Criterion validity, 60 Critical incident stress debriefing, 151 Cross-dependent narcotics, 314 Cross-dressing, 401-402 Cross-fostering, 108 Cross-sectional design, correlational method and, 105 Cultural factors. See Sociocultural factors Cushing s syndrome, 228-229 Cyclothymic disorder, 220 Cytokines, stress and, 190-191 D D-cycloserine, 152 Dahmer legal case, 523 DARE project, 316 Dark Ages, 9-11 Decnminalization, 4 Defense mechanisms, 18 Deinstutionalization, 13, 538-540 Delirium, late life, 474-475 Delirium tremens (DTs), 280 Delusional disorders/delusions bipolar disorders and, 222 key features and, 327 late life, 482 schizophrenia and, 321-322 Demand-withdraw cycle, 496 Dementia, 467-473 Alzheimer s disease, 468-470 caregiver support and, 473 caused by disease and injury, 471 versus depression, 478-479 frontotemporal, 470 with Lewy bodies, 470-471 medications and prevention, 471-472 psychological treatments, 472 treatment of, 471 vascular, 470 Dementia praecox, 326 Demonology, 8—11 Depakote, 244 Dependent personality disorder, 372-373 Dependent variables, experiments and, 110 Depersonalization, panic attacks and, 123 Depersonalization disorder, 160-161 Depression, 215-219. See also Childhood and adolescent depression; Mood disorders; Suicide affect and neuroticism and, 232 age and, 218-219 Alzheimer s disease and, 471 avoidant personality disorder and, 372 Beck s theory and, 233-234 behavioral activation and, 238-239 behavioral couples therapy and, 240 bipolar disorder and, 236 brain-imaging studies and, 226-228 cardiovascular disease and, 479 childhood, 433-438 co-morbidity and, 219 cognitive theories and, 233-236 cognitive therapy and, 238—239 conduct disorder and, 427 consequences of, 218 Cortisol dysregulation and, 228-229 Subject Index S5 versus dementia, 478-479 dysthymic disorder, 216-219 electroconvulsive therapy and, 241 epidemiology of, 217-218 expressed emotion and, 230 Freud s theory and, 231-232 gender factors and, 217 genetic factors and, 223-224 hopelessness theory and, 234-236 interpersonal difficulties and, 230-231 interpersonal psychotherapy and, 237-238 late life, 478-481 life events and, 230-231 major depressive disorder, 216-219 MDD treatment comparison, 243-244 medications for, 241-243 mindfulness-based therapy and, 239 negative self-concept and, 231 neurobiological factors and, 223-229 neurotransmitters and, 224-226 primary care and, 245-246 problem-solving skills and, 231 psychological factors in, 231-236 psychological treatment of, 237-240 seasonal affective disorder, 218 sexual dysfunction and, 391 social factors and, 230-231 social support and, 230 subclinical depression, 216 subtypes of, 222 symptoms of, 215-216 Derailment, schizophrenia and, 324 Derealization, panic attacks and, 123 Desipramine, 313 Desire phase, sexual response cycle, 384 Detoxification, 305-306, 312 Developmental factors, schizophrenia and, 336-337, 340-341 Developmental psychopathology, 418. See also Childhood disorders Dexedrine, 291 Dhat, 67 Diagnosis and assessment. See also assessment types Bedford College Life Events and Difficulties Schedule, 78-79 behavioral and cognitive assessment, 85-88 brain imaging, 89-90 clinical interviews, 74-76 cognitive-style questionnaires, 86 cultural bias and, 94-96 daily experience assessment, 78 direct observation of behavior, 85 general criticisms of, 73 intelligence tests, 84-85 neuropsychological assessment, 91-92 neurotransmitter assessment, 90-91 personality tests, 79-83 projective personality tests, 82-83 psychophysiological assessment, 92-93 reliability and, 59-60 self-observation, 85-86 self-report personality inventories, 79-82 social readjustment rating scale, 76 stress assessment, 76-79 structured interviews, 75 validity and, 60-62 Diagnostic and Statistical Manual oj Mental Disorders (DSM-IV-TR), 62-73 categorical vs. continuum diagnoses, 70-71 categories in need of further study, 67 category validity and, 71-73 defining mental disorders and, 4-7 ethnic and cultural considerations and, 65-69 history of, 64 improvements in, 64-65 multiaxial classification system, 62-63 number of diagnostic categories, 65,70 possible changes for DSM-Y 73 reliability of, 71 specific criticisms of, 70-73 Dialectical behavior therapy, 377-378 Diathesis-stress paradigm, 53-55, 364-365 Diet fads, 267 Dietary-depressive subtypes, 257 Dietary restraint scale, 263 Direct observation of behavior, 85 Directed masturbation, 394 Directionality problem, correlational method and, 105 Disability, defining mental illness and, 5-6 Discrimination, health problems and, 206 Discriminatory laws, 4 Disorganized schizophrenia, 324-325, 327 Disorientation, Alzheimer s disease and, 468 Dissociation and memory, 157 Dissociative disorders definition of, 157 depersonalization disorder and, 160-161 dissociative amnesia, 158-159 dissociative fugue, 160 dissociative identity disorder, 161-167 explicit memory and, 158-159 implicit memory and, 159 post-traumatic stress disorder and, 143-144 stress and, 157 Dissociative fugue, 160 Dissociative identity disorder, 161-167 age regression and, 166-167 childhood abuse and, 163 clinical description of, 161-163 clinician detection patterns and, 165 emergence after treatment starts, 165 epidemiology of, 162-163 etiology of, 163-164 handwriting samples and, 166 hypnosis and, 166-167 implicit memory and, 165 insanity defense and, 528 posttraumatic model and, 163 psychodynamic treatment and, 166 role-playing and, 164-165 sociocognitive model and, 163 treatment of, 166-167 Divalproex sodium, 244 Dizygotic (DZ) twins, 108 DNA transcription, 31-32 Donepezil, 471 Dopamine eating behavior and, 263 mood disorders and, 224-225 psychopathology and, 35 schizophrenia and, 332-334 Dot probe task, 134 Double-blind procedures, 112 Down syndrome, 108-109, 447 Dramatic/erratic cluster, personality disorders and, 362-371 Drug abuse. See Substance-related disorders Drug-rehabilitation homes, 313-314 Drug replacement treatment and medications, 314-316 DTNBP1 gene, 331 Dual allegiance, 544 Dysfunction, defining mental illness and, 7 Dysfunctional Attitudes Scale (DAS), 86, 233 Dyslexia, 442-443 Dyspareunia, 389 Dysthymic disorder, 216-219. See also Depression Eating disorders anorexia nervosa, 254-256 binge eating disorder, 259-260, 275 bulimia nervosa, 256-258 child abuse and, 271 cognitive behavioral views, 264-266 cross-cultural studies and, 268-269 ethnic differences and, 269-270 family characteristics and, 271 gender influences and, 267-268 genetic factors and, 261-262 medications and, 272-273 neurobiological factors and, 262-263 obesity and, 259-260 personality influences and, 270-271 preventative interventions for, 276 psychodynamic views and, 263-264 psychoeducational approaches and, 276 psychological treatment of, 273-275 risk factor approach and, 276 sociocultural factors and, 52, 266-270, 276 treatment of, 272-276 Eating Disorders Inventory, 254-255 Echolalia, 453 Ecological momentary assessment, 86 Ecstasy, 295-296 Education and training, 5 Effectiveness, treatments. See Treatment outcome research Ego, 17-18 Ego analysis, 21 S6 Subject Index Ego-dystonic homosexuality, 383 Egoistic suicide, 248-249 Electrocardiograms (EKG), 92 Electroconvulsive therapy (ЕСТ), 15,241,480 Electrodermal responding, 92 Electroencephalograms (EEG), 93 Emotion-focused coping, 186 Emotion-focused therapy, 492 Emotional components, psychopathy and, 369-370 Emotional disturbances, autism and, 452-453 Emotionally focused couples therapy, 497 Emotions, psychopathology and, 49-50 Empathy, 491 Empirically supported treatments, 500 Employment, 4 Empty-chair technique, 492 Encephalitis, 471 Endogenous opioids, eating disorders and, 262 Enhancement therapy, 313 Enhancing Recovery in Coronary Heart Disease (ENRICHD), 209 Enlarged ventricles, schizophrenia and, 335 Entactogens, 295 Environmental-change approaches, stress and, 211-212 Environmental hazards, mental retardation and, 448 Environmental toxins, attention- deficit/hyperactivity disorder and, 423 Episodic disorder, 216 Erectile dysfunction, 388, 395 Essential hypertension, 192-195 angry thoughts and, 194, 209 cardiovascular reactivity and, 194-195 clinical description of, 193 etiology of, 193 exercise and, 209 stress and, 187-188, 193-194 treatment of, 208-209 type A behavior pattern and, 194 Ethical dilemmas, 541-544 confidentiality and, 543 dual allegiance and, 544 informed consent and, 542-543 privileged communication and, 543 research restraints and, 541-542 Ethnicity assessment and, 94-96 cancer and, 207 cardiovascular disease and, 207 DSM-1V-TR and, 65-69 eating disorders and, 269-270 health and, 207 prevalence rates and, 52 psychological treatments and, 508-510 Excitement phase, sexual response cycle, 384 Exelon, 471 Exercise exercise-induced asthma, 199 hypertension and, 209 memory problems and, 472 Exhibitionism, 405-406 Exorcism, 9 Expectancies, alcohol and drug effects and, 301-302 Experiential therapies, 491-492 client-centered therapy, 491-492 emotion-focused therapy, 492 Gestalt therapy, 492 outcome studies and, 505-506 Experiments, 110-115 analogue experiments, 113-114 basic features of, 110 control groups and, 111 dependent variables and, 110 experimental effect, 110 external validity and, 111-113 independent variables and, 110 internal validity and, 110-111 placebos and, 111 random assignment and, 110 single-subject experiments, 114-115 Explicit memory, dissociative amnesia and, 158-159 Exposure and ritual prevention (ERP), 149 Exposure-focused therapy anxiety disorder and, 146 example of, 493 obsessive-compulsive disorder and, 149 phobias and, 146-147 Expressed emotion, 230, 339-340 External validity, experiments and, 111-113 Externalizing disorders, childhood. See also Childhood disorders Extinction, 22 Extrapyramidal side effects, antipsychotic drugs and, 343 Extroversion, depression and, 232 Eye movement desensitization and reprocessing (EMDR), 150 Factitious disorder, 168 Family check up (FCU), 430 Family environment antisocial personality disorder and, 369 asthma and, 200 eating disorders and, 271 psychopathology and, 369 schizophrenia and, 338-340 substance-related disorders and, 303 Family method, behavior genetics and, 107 Family studies, schizophrenia and, 328 Family therapy, 497-498 anorexia nervosa and, 273 bipolar disorder and, 240 bulimia nervosa and, 275 conduct disorder and, 430-431 schizophrenia and, 348-349 Fear circuit, 131 Fear-of-fear hypothesis, 130 Federal Mental Health Parity Act (1996), 4 Feingold s theory, 423 Female orgasmic disorder, 388-389 Female sexual arousal disorder, 388 Fenfluramine, 459 Fetal alcohol syndrome, 283 Fetishism, 401 First-generation antipsychotic drags, 342-344 Five-factor model, 359-360 Fixation, 19 Flashbacks, hallucinogens and, 295 Flat affect, schizophrenia and, 323-324 Flight of ideas, 219 Fluoxetine, 272 Forced medication, criminal commitment and, 527 Forced rape. See Rape Forcible medication, 537-538 Forensic hospitals, 13 Formal thought disorder, 324-325 Fragile X syndrome, 447 Free association, 18 Freedom Center, 5 Friends Asylum, 12 Frontal lobe, 36 Frontotemporal dementia, 470 Frotteurism, 406 Fugue, dissociative, 160 Functional activation studies, mood disorders and, 226-228 Functional MRI (fMRI), 89 Functional social support, 187-188 G G-proteins, 226 Gamma-aminobutyric acid (GABA), 35 Gender anxiety disorders and, 128-12 , body dysmorphic disorder and, 170 coronary heart disease and, 205 depressive disorders and, 217 dieting and, 267 eating disorders and, 267-268 hypertension and, 194 infectious diseases and, 205-206 mortality and morbidity rates and, 204-206 personality disorders and, 357 sexuality and, 382-384 type A behavior and, 205 Gender identity disorder, 396-400 behavior treatment and, 399 clinical description of, 396 genetic factors and, 397 neurobiological factors and, 397 plastic surgery and, 398 psychological factors and, 397-398 sex-reassignment surgery and, 398-399 social factors and, 397-398 Gene-environment interactions, 31-32 Gene expression, 29 General adaptation syndrome, 184-185 General paresis, 14-15 Generalized anxiety disorder, 124-125 cognitive factors and, 140 etiology of, 140 psychological treatment of, 148-149 Genes, 29 Genetic factors Alzheimer s disease and, 469 antisocial personality disorder and, 369 anxiety disorders and, 131 attention-deficit/hyperactivity disorder and, 422 autism and, 455 conduct disorder and, 428-429 gender identity disorder and, 397 mental retardation and, 447 mood disorders and, 223-224 obesity and, 260 psychopathy and, 369 schizophrenia and, 328-332 somatoform disorders and, 177 substance-related disorders and, 298-299 Genetic paradigm, 29-34 behavior genetics, 30-31 evaluating, 33 Subject Index S7 gene-environment interactions, 32-33 molecular genetics, 31-32 reciprocal gene-environment interactions, 33 Genital stage, psychosexual development and, 19 Genome-wide scans, schizophrenia and, 331 Genotypes, 30 Gestalt therapy, 492 Ghost sickness, 67 Glutamate, 334 Grandiose delusions, 322 Gray matter, 36 Group therapy, 13 Guided self-change, 309 Guilty but mentally ill (GBMI), 519,523-524 H Hallucinations bipolar disorders and, 222 schizophrenia and, 322 Hallucinogens, 294-295 Haloperidol, 459 Halstead-Reitanneuropsychological test battery, 91-92 Handwriting samples, dissociative identity disorder and, 166 Harmful dysfunction, 7 Harmful treatments, 501-502 Hashish, 285 Head Start, 431 Health psychology, 184 Heroin, 289-291, 313 Heroin substitutes, 314-315 High-risk method, schizophrenia and, 106 Hikikomori, 52, 68 Hinckley legal case, 521-522 Hippocampus depression and, 226-227 diagram of, 37 hormones and, 142-143 schizophrenia and, 337 History, 8-13 asylum development, 11-13 of classification and diagnosis, 64 Dark Ages, 9-11 demonology, 9-11 early biological explanations, 9 early demonology, 8-9 lunacy trials, 10-11 mental hospitals today, 13 moral treatment, 12-13 persecution of witches, 10 Pinel s reforms, 12 Histrionic personality disorder, 365 Homelessness, 4-5 Homosexuality, historical classification of, 383 Hopelessness theory, depression and, 234-236 Hormonal agents, paraphilias and, 410 Hormone replacement therapy, 204 Hospital funding, 13 Hostility coronary heart disease and, 197 reducing, 209 Hot cognitions, 495 Housing options, 4—5 ΗΡΑ axis, 38, 228-229 Hydrocodone, 289-291 Hypertension. See Essential hypertension Hypnosis, 17, 166-167 Hypnotizability, 53 Hypoactive sexual desire, 387-388 Hypochondriasis, 171, 180 Hypomania, 220 Hypothalamus, 37, 262 Hypotheses, 98, 101 Hysteria, 16, 173 Hysterical blindness, 175 I Ideal affect, 50 Ideas of reference, 322 Illicit drug use. See Substance- related disorders Imaginai exposure, 45, 150 Immobility, catatonic, 325 Immune system components of, 190 stress and, 189-191 Implicit memory dissociative amnesia and, 159 dissociative identity disorder and, 165 Impulse control disorders, 494 Impulsivity, psychopathy and, 370-371 In absentia trials, 525 In vivo (learned) exposure to feared objects, 146 Inappropriate affect, schizophrenia and, 325 Incentive-sensitization theory, 299 Incest, 404-406 Independent variables, experiments and, 110 Index cases, behavior genetics and, 107 Indiana v. Edwards (2008), 527 Individual psychology, 20-21 Infectious diseases gender and, 205-206 mental retardation and, 448 Informed consent, 542-543 Insanity defense, 519-524 American Law Institute guidelines and, 521 dissociative identity disorder and, 528 guilty but mentally ill, 519, 523-524 Insanity Defense Reform Act and, 521-523 irresistible impulse concept and, 520 landmark cases and laws, 520-524 M Naghten rale and, 520 not guilty by reason of insanity plea, 519 standards of proof and, 523 Insanity Defense Reform Act, 521-523 Insurance coverage, 4 Integrative behavioral couples therapy (ІБСТ), 496 Intellectual functioning, marijuana use and, 286 Intelligence, post-traumatic stress disorder and, 144 Intelligence tests, 31, 84-85, 429, 445 Interdisciplinary health care teamwork, 485 Interleukin-6, 190-191 Internal consistency reliability, 60 Internal validity, experiments and, 110-111 Internalizing disorders, childhood. See also Childhood disorders Interoceptive conditioning, panic disorders and, 138 Interpersonal deficits, 43 Interpersonal relationship importance, 42-43 Interpersonal therapy, 43-44, 237-238 Interpretation, 20 Interrater reliability, 60, 71, 76 Interviews. See Clinical interviews Intravenous drug use, AIDS and, 291 Irresistible impulse concept, 520 Jackson v. Indiana (1972), 526-527 Job strain, myocardial infarction and, 196 Joe Camel, 304 Joint attention, 452 Jones legal case, 523-524 К Kayak-angst, 129 Kelly legal case, 529 Koro, 67, 129 Kyofusho, 129 Kyol goeu, 129 La belle indifference, 168 Lamictal, 244 Lamotrigene, 244 Late life. See also Late life psychological disorders adjusting treatment and, 484 age effects and, 465 alternative living settings and, 487-488 Alzheimer s disease and, 468-470 cognitive disorders in, 467-475 cognitive functioning and, 463-464 cohort effects and, 465 delirium and, 474-475 demarcation points and, 462-463 dementia and, 467-473 dementia with Lewy bodies and, 470-471 frontotemporal dementia and, 470 interdisciplinary health care teamwork, 485 living situations and, 485-488 myths regarding, 463-464 nursing homes and, 486-487 polypharmacy and, 464-465 problems experienced in, 464-465 psychological disorders in, 476-483 research methods and, 465-466 sexual interest and capacity and, 464 sleep quality and, 464 social problems and, 462 social selectivity and, 464 time-of-measurement effects and, 465 vascular dementia and, 470 Late life psychological disorders, 476-483 anxiety disorders, 481-482 delusional (paranoid) disorders, 482 depression vs. dementia, 478-479 etiology of depression, 479-480 major depressive disorder, 478-481 medical issues in diagnosing, 478 prevalence of, 476-478 S8 Subject Index Late life psychological disorders (cont.) substance abuse and dependence, 483 suicide and, 481 treatment of depression, 480-481 Latency period, psychosexual development and, 19 Latinos, therapeutic considerations and, 508-510 Laughing gas, 296 Law of effect, 23 Lead-based paint, 448-449 Lead poisoning, 423 Learned helplessness theory, 234-236 Learning disabilities, 441-444 clinical descriptions and, 442 dyslexia, 442-443 etiology of, 442-444 mathematics disorder and, 443-444 treatment of, 444 Least restrictive alternative, 533-534 Legal issues. See Civil commitment; Criminal commitment; Insanity defense Lessard v. Schmidt (1976), 533 Levitra, 395 Lewy bodies, 470-471 Libido, 17 Life events asthma and, 199 depression and, 230-231 timeline, 79 Limbie system, 37 Linkage analysis, 108-109 Lithium, bipolar disorder and, 244 Live Change Unit (LCU) scale, 76 Living situations, late life, 485-488 Lobotomy, 15-16 Locus ceruleus, panic disorders and, 137-138 Longitudinal design, correlational method and, 105 Loose associations, schizophrenia and, 324 LSD, 294-295 Lunacy trials, 10-11 Luria-Nebraska battery, 92 M Magnetic resonance imaging (MRI), 89 Major depressive disorder (MDD), 216-219, 478-481. See also Depression Male erectile disorder, 388 Male orgasmic disorder, 389 Malingering, 168 Mania bipolar disorder and, 236 criteria and, 219 hypomania, 200 Marijuana, 285-288 historical aspects of, 285-286 physical consequences and, 286-287 psychological effects and, 286 therapeutic effects of, 287-288 use prevalence and, 286 Marriage therapists, 26 Masochism, sexual, 406 Mass media, substance-related disorders and, 303-304 Masturbation, directed, 394 Maternal smoking, 423 Mathematics disorder, 443-444 MATRICS project, 345 Matrix treatment, 316 McArthur Violence Risk Assessment Study, 531 MDA, 295 MDMA, 295 Media influences, substance-related disorders and, 303-304 Medicaid, 13 Medicare, 13 Megan s law, 410 Melancholia, 222 Memantine, 471 Memory. See also Dissociative disorders aids, 472 child abuse and, 158-159 dissociation and, 157 dissociative amnesia and, 159 dissociative identity disorder and, 165 exercise benefits and, 472 explicit, 158-159 implicit, 159 marijuana use and, 287 post-traumatic stress disorder and, 143-144 recovered, 158—159 Meningitis, 471 Mental disorders, definition of, 4-7 Mental health evaluations, 5 Mental health professionals, 25-26 Mental retardation, 444-450 AAIDD approach and, 445-447 accidents and, 448 adaptive functioning and, 445 age of onset and, 445 autism and, 451-452 behavioral treatments and, 449 capital punishment and, 530 chromosomal abnormalities and, 447 cognitive treatments and, 449 computer-assisted instruction and, 449-450 Down syndrome and, 447 DSM-IV-TR categories of, 445 environmental hazards and, 448 etiology of, 447-448 fragile x syndrome and, 447 genetic abnormalities and, 447 infectious diseases and, 448 intelligence test scores and, 444-445 levels of, 445 recessive-gene diseases and, 448 residential treatment and, 449 treatment of, 449-450 Mescaline, 295 Meta-analysis, 116-117 Metabolite studies, 90 Methadone, 314-315 Methamphetamine, 293, 315-316 Methedrine, 291 Methylphenidate, 424-425 Miami Vice, 304 Mind Freedom International, 5 Mindfullness-based cognitive therapy, 239 Minnesota Multiphasic Personality Inventory (MMPI), 79-82 Minority populations, treatment outcomes and, 508-510 Mixed manic episodes, 219-220 M Naghten rule, 520 Modeling, 23-24 Molecular genetics alíeles and, 31 association studies and, 109 DNA transcription and, 31-32 linkage analysis and, 108-109 polymorphism and, 31 schizophrenia and, 330-331 Monoamine oxidase (MAO) inhibitors, 241-243 Monozygotic (MZ) twins, 108 Mood alteration, substance-related, 300-301 Mood disorders. See also Bipolar disorders; Depression biological treatment of, 241-244 brain-imaging studies and, 226-228 catatonic features and, 222 cortisol dysregulation and, 228-229 creativity and, 221 episodic disorder, 216 etiology of, 223-236 genetic factors and, 223-224 melancholic features and, 222 neurobiological factors and, 223-229 neurotransmitters and, 224—226 psychological treatment of, 237-241 psychotic features and, 222 rapid cycling and, 222 subtypes and, 222 suicide and, 246-251 treatment of, 237-245 Mood stabilizing medications, 241, 244 Moral awareness, 429 Moral treatment, 12-13 Morphine, 289-291 Mortality, social support and, 187 Motivational interviewing, 313 Mowrers two-factor model, 135 Multiaxial classification system, 62-63 Multiple studies, integrating findings of, 116-117 Multisystemic treatment, 432 Munchausen syndrome, 168 Myocardial infarction, stress and, 195-196 N Naloxone, 310, 315 Naltrexone.310, 315, 459 Namenda, 471 Narcissistic personality disorder, 365-367 etiology of, 366 self-psychology model and, 366 social-cognitive model and, 366-367 National Alliance on Mental Illness, 5 National Comorbidity Survey- Replication study, 260 National Depression Awareness Day, 515 Natural immunity, 190 Negative cognition, anxiety disorders and, 133-134 Negative emotionality, 302 Negative reinforcement, 23 Negative schemata, depression and, 233 Negative self-evaluation, 137 Negative triad, depression and, 233 Neo-Freudian psychodynamic perspectives, 20-21 NEO Personality Inventory, 359 Nerve impulses, 34 Neurobiological assessment, 88-94. See also Biological approaches brain imaging, 89-90 cautionary note regarding, 93 neuropsychological assessment, 91-92 Subject Index neurotransmitter assessment, 90-91 psychophysiological assessment, 92-93 Neurobiological factors anxiety disorders and, 131-132 attention-deficit/hyperactivity disorder and, 422-423 autism and, 455-457 borderline personality disorder and, 363-364 eating disorders and, 262-263 gender identity disorder and, 397 obsessive-compulsive disorder and, 140 panic disorder and, 137-138 paraphilias and, 406-407 post-traumatic stress disorder and, 142-143 schizophrenia and, 334-337 stress and, 189-191 substance-related disorders and, 299-300 suicide and, 247-248 Neurofibrillary tangles, 468-469 Neuroleptic malignant syndrome, 343 Neurologists, 91 Neurons, 34-36, 336 Neuropsychological assessment, 91-92 Neuropsychologists, 91 Neuroscience paradigm, 34-40 evaluating, 40 neuroendocrine system, 38 neurons and neurotransmitters, 34-36 neuroscience treatment approaches, 38-40 structure and function of human brain, 36-38 Neuroscience treatment approaches, 38-40 Neurosis, 131 Neuroticism anxiety disorders and, 132 depression and, 232 Neurotransmitter assessment, 90-91 Neurotransmitters anxiety disorders and, 131-132 functions of, 34-36 schizophrenia and, 332-334 Nicotine gum, 311-312 Nicotine patches, 312 Nicotine use. See also Cigarette smoking attention-deficit/hyperactivity disorder and, 423 dependence and, 310-312 health consequences and, 284-285 nicotine replacement treatments and medications, 311-312 psychological treatments and, 311 replacement treatments and, 311 stress and, 300 Nitrous oxide, 296 Nonpurging type, bulimia nervosa, 257 Nonshared environment, 30 Norepinephrine mood disorders and, 224-225 psychopathology and, 35 Not guilty by reason of insanity plea (N GRI), 519 Numbing of responsiveness, 127 Nuremberg Code, 542 Nursing homes, 486-487 Nuthkavihak, 51 О Obesity, 259-260 Object relations psychotherapy, 377 Object relations theory, 42, 364 Objedification theory, 268 Obsessions, 125 Obsessive compulsive disorder (OCD) anterior cingulate and, 140 childhood and adolescent, 439 cognitive factors and, 141-142 criteria and, 125-126 etiology of, 140-142 neurobiological factors and, 140 orbitofrontal cortex and, 140 psychological treatment of, 149 thought suppression and, 141-142 Obsessive-compulsive personality disorder, 373-374 Occipital lobe, 36 O Connor v. Donaldson (1975), 536-537 Odd/eccentric cluster, personality disorders and, 360-362 Olanzapme, 244, 344-345 Older adults. See Late life Operant conditioning, 23-24, 135 Opiates, 289-291 abuse and dependence and, 289-290 physical effects and, 290-291 psychological effects and, 290-291 synthetic sedatives, 291 types of, 289 Opium, 289-291 Oppositional defiant disorder (ODD), 426 Oral stage, psychosexual development and, 19 Orbitofrontal cortex, obsessive- compulsive disorder and, 140 Orgasm phase, sexual response cycle, 384 Orgasmic disorders, 388-389 Outpatient commitment, 532-533 Oxycodone, 289-291 Pacific Islanders, therapeutic considerations and, 508-511 Pain disorder psychological factors and, 169 sexual, 389 treatment of, 179 Pain management, 180 Panetti legal case, 529-530 Panic attacks, 123-124 Panic control therapy, 148 Panic disorder, 123-124 Anxiety Sensitivity Index and, 139 behavioral factors and, 138 cognitive factors and, 138-139 cognitive process and, 178 etiology of, 137-139 interoceptive conditioning and, 138 neurobiological factors and, 137-138 psychological treatment of, 147-148 sexual dysfunction and, 391 Paradigms characteristics of, 28-29 cognitive behavioral paradigm, 44-48 diathesis-stress paradigm, 53-55 emotions and, 49-50 genetic paradigm, 29-34 multiple perspectives and, 55-56 neuroscience paradigm, 34-40 psychodynamic paradigm, 41-44 sociocultural factors and, 51-52 Paranoia, 482 Paranoid personality disorder, 360 Paranoid schizophrenia, 327 Paraphilias, 400-411 aversion therapy and, 409-410 biological treatment and, 410 cognitive behavioral treatment and, 409-410 etiology of, 406-408 exhibitionism, 405-406 fetishism, 401 frotteurism, 406 incest and, 404-406 neurobiological factors and, 406-407 pedophilia, 402-404 prevalence statistics and, 400-401 psychodynamic perspectives and, 407 psychological factors and, 407-408 sexual masochism, 406 sexual sadism, 406 social skills and, 407-408 transvestic fetishism, 401-402 treatments for, 408-410 voyeurism, 405 Parasympathetic nervous system, 39 Parent-child relationships, paraphilias and, 408 Parent management training (PMT), 431 Parent training, attention- deficit/hyperactivity disorder, 425 Parenting behaviors, nongenetic transference and, 32-33 Paresis, 14-15 Parietal lobe, 36 Parkinson s disease, 332, 470-471 Pate v. Robinson (1966), 524-525 Patient rights protection, 533-538 deinstutionalization and, 538-540 least restrictive alternative concept and, 533-534 right to refuse treatment, 537-538 right to treatment, 534-537 Paul Wellstone Mental Health and Addiction Equity Act (2008), 4 Pedophilia, 402-404 Peer influences, conduct disorder and, 430 Peer leadership, substance-related disorders and, 317 Peer-pressure resistance training, 317 Penile plethysmograph, 391 Perceived control, anxiety disorders and, 133 Perception disturbances, schizophrenia and, 322 Perfectionism, anorexia and, 270 Performance fears, sexual, 389 Perinatal factors, attention- deficit/hyperactivity disorder and, 423 S10 Subject Index Personal distress, defining mental illness and, 5-6 Personality disorders antisocial personality disorder, 367-371 anxious/fearful cluster of, 372-374 associated maladaptive cognitions and, 376 avoidant personality disorder, 372 borderline personality disorder, 362-365 classification of, 356-360 cognitive behavioral therapists and, 375-376 comorbidity and, 358-359 day treatment programs and, 375 dependent personality disorder, 372-373 diagnostic reliability and, 356-358 dramatic/erratic cluster of, 362-371 DSM-IV-TR approach and, 356-359 five-factor model and, 359-360 gender and, 357 histrionic personality disorder, 365 medications and, 375 narcissistic personality disorder, 365-367 obsessive-compulsive personality disorder, 373-374 odd/eccentric cluster of, 360-362 paranoid personality disorder, 360 psychodynamic therapy and, 375 psychopathy and, 367-371 schizoid personality disorder, 360-361 schizotypal personality disorder, 361 treatment of, 375-379 Personality factors eating disorders and, 270-271 stress and, 191 substance-related disorders and, 302 Personality inventories, 79-82 Personality tests, 79-83 projective personality tests, 82-83 self-report personality inventories, 79-82 Pervasive developmental disorders (PDDs), 451. See also Asperger s disease; Autistic disorder Phallic stage, psychosexual development and, 19 Phencyclidine (PCP), 295-296 Phenothiazines, 342-344 Phenotypes, 30-31 Phenylketonuria (PKU), 448 Phobias, 121-123 agoraphobia, 124 combining medications with psychological treatment in, 152-153 comorbidity and, 122 definition of, 121 generalized anxiety disorder, 124-125 obsessive-compulsive disorder, 125-126 panic disorder, 123-124 post-traumatic stress disorder, 126-127 psychological treatment of, 146-147 social phobia, 122-123 specific phobia, 121-122 spectrum model of, 123 in vivo exposure and, 146 Physical consequences, marijuana use and, 286-287 Physical effects, opiates and, 290-291 Physician-assisted suicide, 248 Pick s disease, 470 Pineis reforms, 12 Placebo effect, 112 Placebos, experiments and, 111 Plaques, Alzheimer s disease and, 468-469 Plastic surgery, gender identity disorder and, 398 Pleasure principle, 17 Point systems, attention- deficit/hyperactivity disorder, 425 Policy and legislative strategies, 4 Polydrug abuse, alcohol and, 280 Polygenic psychopathology, 29-30 Polymorphism, 31 Polypharmacy 464-465 Positive affect, depression and, 232 Positive reinforcement, 23 Positive symptoms, schizophrenia and, 321-322 Positron emission tomography (PET scan), 89-90 Post-traumatic stress disorder, 126-127 behavioral factors and, 143 childhood sexual abuse and, 404 dissociation and, 143-144 etiology of, 142-145 hippocampus and hormones and, 142-143 imaginai exposure treatment and, 150 intelligence and, 144 memory suppression and, 143-144 neurobiological factors and, 142-143 psychological factors and, 143-144 psychological treatment of, 150-151 social support and, 144 trauma severity and type and, 142 two-factor model and, 143 virtual reality technology and, 150 Postpartum onset, mood disorders and, 222 Posttraumatic model, dissociative identity disorder and, 163 Poverty, 369 Prediction of dangerousness, 532-533 Predictive validity, 60 Prefrontal cortex depression and, 226-227 functions and, 36 schizophrenia and, 331, 335-336 Prefrontal lobotomy 15-16 Premature ejaculation, 389, 391, 394, 395 Prenatal factors, attention- deficit/hyperactivity disorder and, 423 Prepared learning, 136 Preventative detention, 531-533 Prevention centers, suicide, 251 Prevention science projects, 515 Primary care, depression and, 245-246 Private hospitals, 13 Privileged communication, 534-535, 543 Probands, 107 Problem-focused coping, 186 Problem-solving skills, depression and, 231 Problem-solving therapy (PST), 210 Project DARE (Drug Abuse Resistance Education), 316 Projective hypothesis, 82 Projective personality tests, 82-83 Pronoun reversal, 453 Protective acts, compulsions and, 125 Protein kinase C, 228 Prozac, 272 Pruning, 38 Psilocybin, 295 Psyche, 17 Psychiatric nurses, 26 Psychiatrists, 25-26 Psychoactive medications, 26 Psychoanalytic theory, 17-20 defense mechanisms and, 18 ego and, 17-18 free association and, 18 interpretation and, 20 libido and, 17 pleasure principle and, 17 psyche and, 17 psychoanalytic therapy and, 18-19 reality principle and, 18 repression and, 18 structure of mind and, 17-18 superego and, 18 transference and, 20 unconscious and, 17 Psychodynamic paradigm, 41-44 cognitive behavioral paradigm compared, 48 contemporary psychodynamic perspectives, 43-44 evaluating, 44 interpersonal relationships, 42-43 role of unconscious and, 41-42 Psychodynamic perspectives conversion disorder, 175 paraphilias and, 407 stress and, 191 Psychodynamic therapy approaches to, 491 dissociative identity disorder and, 166 eating disorders and, 263-264 insight-oriented couples therapy, 497 outcome studies and, 505 panic disorder and, 147 personality disorders and, 375 somatoform disorders and, 178 Psychoeducational approaches bipolar disorder and, 240 eating disorders and, 276 Psychoimmunology, 189 Psychological approaches, 16-24 Adler and individual psychology, 20-21 behavior therapy, 24 behavioral and cognitive assessment, 85-87 behaviorism, 22-24 Breuer and cathartic method, 17 classical conditioning, 22-23 Subject Index S11 clinical interviews and, 74-76 ego analysis, 21 Freud and psychoanalysis, 17-20 intelligence tests, 84-85 Jung and analytical psychology, 20 Mesmer and Charcot, 16-17 modeling, 23-24 neo-Freudian psychodynamic perspectives, 20-21 operant conditioning, 23-24 personality tests, 79-83 stress assessment, 76-79 Psychological factors attention-deficit/hyperactivity disorder and, 423-424 bipolar disorder and, 236 conduct disorder and, 429-430 depression and, 231-236 gender identity disorder and, 397-398 late life disorders and, 478-483 marijuana use and, 286 opiates and, 290-291 paraphilias and, 407-408 post-traumatic stress disorder and, 143-144 schizophrenia and, 337-340 substance-related disorders and, 300-302 suicide and, 247, 249 Psychological treatment. See also Psychotherapy/psychoanalysis; Treatment outcome research acute stress disorder and, 151 agoraphobia and, 147-148 anorexia nervosa and, 273 attention-deficit/hyperactivity disorder, 425-426 behavioral therapies, 493-494 bmge eating disorder and, 275 bipolar disorder and, 240 bulimia nervosa, 274-275 client-centered therapy, 491-492 cognitive treatment, 494-495 community psychology and, 514-515 couples therapy, 495-496 culture and, 508-510 dementia and, 472 depression and, 237-240 emotion-focused therapy, 492 ethnicity and, 508-509 experiential therapies and, 491-492 family therapy, 497-498 generalized anxiety disorder and, 148-149 Gestalt therapy, 492 illicit drug abuse and dependence and, 312-313 nicotine dependence and, 311 obsessive-compulsive disorder and, 149 panic disorder and, 147-148 phobias and, 146-147 posttraumatic stress disorder, 150-151 psychodynamic treatment, 491 psychotherapy process research, 512-514 rapists and, 413-414 schizophrenia and, 346-351 specific approaches to, 490-498 treatment outcome research and, 499-508 Psychomotor agitation, 216 Psychomotor retardation, 216 Psychomotor skills, marijuana use and, 286 Psychopathology emotions and, 49-50 sociocultural factors and, 51-52 treatment controversies in children, 436-437 Psychopathy, 367-371 clinical description of, 368 emotional components and, 369-370 etiology of, 368-371 family environment and, 369 genetic factors and, 369 impulsivity and, 370-371 poverty and, 369 response modulation and, 370-371 social factors and, 369 treatment of, 379 Psychopathy Checklist-Revised, 368 Psychophysiology, 92-93 Psychosexual development stages, 19 Psychosocial interventions, childhood and adolescent depression and, 435 Psychotherapy process research, 512-514 change research mechanisms and, 513-514 common factors research, 512-513 Psychotherapy/psychoanalysis anxiety disorders and, 131 approaches to, 491 borderline personality disorder and, 377-379 childhood and adolescent depression and, 438 dementia and, 472 depression and, 237-238 interpersonal relationships and, 43-44 mental health professionals and, 25 outcome studies and, 505 schizophrenia and, 346-347 Psychotic features, mood disorders and, 222 Purging type, bulimia nervosa, 257 Q Questionnaires, cognitive-style, 86 R Racial stereotypes, 510 Random assignment experiments, 110 Randomized controlled trials. See Treatment outcome research Rape, 411-414 college students and, 411-412 crime specifics and, 412-413 etiology of, 413 forced rape, 411 legal system and, 414 psychological treatment and, 413-414 statutory rape, 411 Rapid cycling, 222 Rational-emotive behavior therapy, 47-48, 495 Reactivity, 86 Reassurance seeking, excessive, 231 Recessive-gene diseases, 448 Reciprocal gene-environment interactions, 33 Recovered memories, 158-159 Relapse prevention, alcohol abuse and, 308 Relational self, 42 Relaxation therapy, 210-211 Reliability, diagnosis and assessment, 59-60 Repetitive acts, autism and, 454 Repetitive checking, compulsions and, 126 Repression, memory, 158-159 Repressive sexual attitudes, 175 Research approaches, 100-109 case studies, 100-103 correlational method, 101-109 experiments, 110-115 multiple studies and, 116-117 Research restraints, 541-542 Residential treatment drag abuse and, 313-314 mental retardation and, 449 schizophrenia and, 350-351 Residual schizophrenia, 327 Resolution phase, sexual response cycle, 384 Response modulation, psychopathy and, 370-371 Restraint scale, dietary, 263 Restricting type, anorexia nervosa, 254-255 Reuptake, 35 Reversal designs, 114-115 Reward system, brain, 228 Right to refuse treatment, 537-538 Right to treatment, 534-537 Risk factor approach, eating disorders and, 276 Risperidone, 344-345 Ritalin, 424-425 Ritualistic acts, autism and, 454 Rivastigmine, 471 Role disputes, 43 Role-playing, 163 Role transitions, 43 Rorschach Inkblot Test, 83 Sadism, sexual, 406 Safety behaviors, anxiety disorders and, 132-133 Scatter diagrams, 105 Schema, 46 Schema-schema-focused cognitive therapy, 378 Schemata, negative, 233 Schizoid personality disorder, 360-361 Schizophrenia adoption studies and, 329-330 alogia and, 323 anhedonia and, 323 anticipatory pleasure and, 323 asociality and, 324 avolition and, 323 behavior genetics research and, 328-330 brain structure and function and, 334-337 case management and, 350 catatonia and, 325 clinical descriptions of, 321-327 cognitive behavior therapy and, 349 cognitive enhancement therapy and, 349-350 conceptual history of, 326 congenital factors and, 336-337 consummatory pleasure and, 323 current research and, 337 delusions and, 321-322 developmental factors and, 336-337 S12 Subject Index Schizophrenia (cont.) developmental studies and, 340-341 disorganized behavior and, 325 disorganized speech and, 324-325 disorganized symptoms and, 324-325 dopamine theory and, 332-334 in DSM-IV-TR, 326-327 enlarged ventricles and, 335 etiology of, 328-341 expressed emotion and, 339-340 family-related factors and, 338-340 family therapies and, 348-349 first-generation antipsychotic drugs and, 342-344 flat affect and, 323-324 genetic factors and, 328-332 hallucinations and, 322 inappropriate affect and, 325 loose associations and, 324 medications and, 342-346 molecular genetics research and, 330-331 negative symptoms and, 323-324 neurotransmitters and, 332-334 new drag development and, 345 perception disturbances and, 322 positive symptoms and, 321-322 prefrontal cortex and, 335-336 psychoanalytic therapy and, 346-347 psychological stress and, 337-340 psychological treatments and, 346-351 residential treatment and, 350-351 second-generation antipsychotic drags and, 344-345 social skills training and, 348 sociocultural factors and, 52 socioeconomic status and, 337-338 subtypes and, 327 treatment of, 342-352 twin studies and, 329 Schizophreniform disorder, 327 Schizotypal personality disorder, 361 School interventions, attention- deficit/hyperactivity disorder, 425 School phobia, 439 Scientific methods, 98-100 Seasonal affective disorder, 218 Second-generation antipsychotic drugs, 344-345 Second messengers, 36, 226 Secondhand smoke, health consequences of, 284 Sedatives. See Opiates Selective mortality, 466 Selective serotonin reuptake inhibitors (SSRIs) anxiety disorders and, 152 depression and, 241-243 older adults and, 480 Self-actualization, 491 Self-concept, depression and, 231 Self-control, 494 Self-evaluation, negative, 137 Self-monitoring, 85-86 Self-observation, 85-86 Self-psychology model, narcissistic personality disorder and, 366 Self-report personality inventories, 79-82 Sensate focus, 393 Sensory-awareness procedures, sexual dysfunction and, 394 Šeptal area, 37 Serotonin autism and, 459 eating disorders and, 263 mood disorders and, 224-225 psychopathology and, 35 schizophrenia and, 334 Serotonin transporter gene, 32, 236 Sex offenders, treatment programs and, 409 Sex-reassignment surgery, 398-399 Sexual abuse. See also Child abuse; Rape childhood, 402-406 dissociative identity disorder and, 163 paraphilias and, 408 Sexual anatomy, 385 Sexual assault. See Rape Sexual aversion disorder, 387-388 Sexual desire disorders, 387-388 Sexual dysfunctions anxiety reduction and, 392-394 attitudes and thoughts and, 394 biological factors and, 390 clinical descriptions of, 385-389 communication training and, 394 couples therapy and, 394 directed masturbation and, 394 distal and immediate causes of, 390 etiology of, 389-392 Masters and Johnsons therapy for, 393 medications and physical treatments and, 395 orgasmic disorders, 388-389 by phase of response cycle, 387 predictors of, 390 psychosocial factors and, 391-392 sexual arousal disorders, 388 sexual desire disorders, 387-388 sexual pain disorders, 389 sexual skill training and, 394 treatment of, 392-395 Sexual interest and capacity, late life and, 464 Sexual masochism, 406 Sexual orientation, 396 Sexual pain disorders, 389 Sexual response cycle, 384 Sexual sadism, 406 Sexuality gender and, 382-384 homosexuality classification, 383 sexual norms and behavior, 381-382 sexual response cycle and, 384 Shaping, 23 Shared environment, 30 Shenjing shuairuo, 67 Shenkui, 129 Short-term memory, marijuana use and, 287 Sildenafil, 395 Single-subject experiments, 114-115 Skin conductance, 92 Skinner boxes, 23 Sleep quality, late life and, 464 Social anxiety disorder, 122 Social-cognitive perspective conduct disorders and, 429-430 dissociative identity disorder and, 163 narcissistic personality disorder and, 366-367 Social deficits, 43 Social factors antisocial personality disorder and, 369 anxiety disorders and, 132 autism and, 452-453 bipolar disorder and, 236 borderline personality disorder and, 364 depression and, 230-231 gender identity disorder and, 397-398 general health and, 187-188 post-traumatic stress disorder and, 144 psychopathology and, 369 substance-related disorders anc 303 Social phobias behavioral factors and, 136 childhood, 439 cognitive factors and, 137 criteria and, 122-123 etiology of, 136-137 negative self-evaluation and, 13 Social Readjustment Rating Scale (SRRS), 76, 78 Social selection theory, 337-338 Social selectivity, late life, 464 Social skills paraphilias and, 407-408 schizophrenia and, 348 Social workers, 26 Sociocultural factors anxiety disorders and, 129-130 attention-deficit/hyperactivity disorder and, 419 bias and, 94-96 conduct disorder and, 430 considerations in DSM-IV-TR, 65-69 conversion disorder and, 176 cultural competence and, 509-510 diversity and assessment, 94-96 eating disorders and, 266-270, 268-269, 276 general health and, 206-207 psychopathology and, 51-52 schizophrenia and, 337-338 sensitivity and psychological treatment outcomes, 508-510 sexual dysfunction and, 392 somatization disorder and, 172-173 substance-related disorders and, 302-303, 302-304 suicide and, 248 Somatic arousal, depression and, 232 Somatization disorder, 171-173, 180-181 Somatoform disorders behavioral techniques and, 179 body dysmorphic disorder, 170, 179 cognitive behavioral models and, 177-178 cognitive strategies and, 179 conversion disorder, 173-177, 181 definition of, 167 genetic research and, 177 grouping of, 169 hypochondriasis, 171, 180 mechanisms involved in, 177 pain disorder, 169, 179 Subject Index S13 psychodynamic treatment and, 178 related disorders and, 167 somatization disorder, 171-173, 180-181 treatment of, 178-181 Something Gotta Give, 395 Specific immunity, 190 Specific phobias, 121-122 behavioral factors and, 135-136 Mowrer s two-factor model and, 135 prepared learning and, 136 Spectator role, sexual, 389 Speech, disorganized, 324-325 Speech sounds perception tests, 91 Spellbound, 159 Standardization, personality tests and, 79 Stanford-Binet, 5th edition, 84 Star charts, attention- deficit/hyperactivity disorder, 425 Statistical significance, correlational method and, 104 Statutory rape, 411-414 Stepped care, 504 Stigma characteristics of, 2-3 strategic approach to, 4-5 Stimulant medications, 291-294 amphetamines, 291-293 attention-deficit/hyperactivity disorder and, 424-425 children and, 436-437 cocaine, 293-294 Stonewalling, 497 Stress alcohol use and, 300 allostatic load and, 189 assessment of daily experience and, 78-79, 185-186 asthma and, 197-200 Beford College Life Events and Difficulties, 78-79, 82 behavioral skills training and, 211 cardiovascular disorders and, 192-197 characteristics of, 184-188 cognitive perspectives and, 191 cognitive restructuring and, 211 coping and health, 186-187 dissociation and, 157 environmental-change approaches and, 211-212 essential hypertension and, 192-195 general adaptation syndrome and, 184-185 immune system and, 189-191 management of, 210-212 myocardial infarction and, 196 neurobiological perspectives and, 189-191 personality perspectives and, 191 personality tests, 79-83 psychodynamic perspectives and, 191 relaxation training and, 210-211 schizophrenia and, 337-340 sexual dysfunction and, 391 Social Readjustment Rating Scale, 76, 78 social support and health, 187-188 stress-illness link, 188-192 Stroop task, 46-47 Structural social support, 187-188 Structural studies, mood disorders and, 226-228 Structured interviews, 75-77 Subclmical depression, 216 Subgenual anterior cingulate, depression and, 226-227 Suboxone, 315 Substance abuse. See Substance- related disorders Substance Abuse and Crime Prevention Act (SACPA), 314 Substance-related disorders advertising and media and, 303-304 alcohol abuse and dependence, 280-283 beliefs and expectations and, 317 caffeine and, 292 categories of, 279 cocaine and, 293-294 drug-rehabilitation homes and, 313-314 drug replacement treatments and medications, 314-316 ecstasy and, 295-296 etiology of, 297-304 expectancies and, 301-302 genetic factors and, 298-299 hallucinogens and, 294-295 illicit drug abuse and dependence, 312-316 late life, 483 marijuana and, 285-288 mass media messages and, 317 mood alteration and, 300-301 neurobiological factors and, 299-300 nicotine and cigarette smoking, 284-285 nitrous oxide and, 296 opiates and, 289-291 peer leadership and, 317 peer-pressure resistance training and, 317 personality factors and, 302 phencyclidine (PCP) and, 295-296 prevalence of, 278-279 prevention of, 316-317 psychological factors and, 300-302 psychological treatments and, 312-313 social setting and, 303 sociocultural factors and, 302-304 stigma and, 279 stimulants and, 291-294 substance abuse and, 279 substance dependence and, 279 treatment of, 305-310 Subthreshold symptoms, 128 Suicide altruistic suicide, 249 annual deaths due to, 247 anomie suicide, 249 associated mental disorder treatment and, 250 common myths regarding, 247 egoistic suicide, 248-249 in elderly, 481 epidemiology of, 246 models of, 247-249 neurobiological models and, 247-248 physician-assisted, 248 prevention centers, 251 prevention of, 249-250 psychological disorders and, 247 psychological models and, 249 sociocultural models and, 248 treating suicidality directly, 250-251 Superego, 18 Support groups, 5 Susto, 129 Sybi!, 163 Sympathetic nervous system, 39 Synapse, 35 Synthetic sanity concept, 527 Synthetic sedatives, 291 Syphilis, 14-15 Systematic desensitization, 24, 146 Tactile performance tests, 91 Tadafil, 395 Taijin kyofusho, 67-68, 129, 372 Tarasoff legal case, 534-535 Tardive dyskinesia, 343 Tension-reducing properties, nicotine and, 300-301 Test-retest reliability, 60 Thalamus, 37, 337 Thematic Apperception Test (TAT), 82-83 Theories, 98-100 Therapeutic alliance, 512 Thinness ideal, 267 Thinsperation, 267 Third-variable problems, 106 Thorazme, 342-344 Thought broadcasting, 321 Thought insertion, 321 Thought suppression, 141—142 Threats attending to, 132 perceived, 133 Three Faces of Eve, 163 Time-of-measurement effects, 465 Time-outs, 45 Token economy, 45 Transference, 20 Transvestic fetishism, 401-402 Traumatic experiences. See also Post-traumatic stress disorder reexperiencing, 127 sexual dysfunction and, 391 Treatment manuals, 502 Treatment of Adolescent Depression Study (TADS), 436 Treatment outcome research, 499-508 brief psychodynamic treatments and, 505 choosing between therapies and, 507-508 cognitive behavior therapy and, 506 couples therapy and, 506-507 culture and ethnicity and, 508-510 defining samples and, 502-503 effectiveness studies and, 503 empirically supported treatments and, 500 experiential therapies and, 505-506 family therapy and, 507 harmful therapy, 501-502 issues in, 501-504 randomized controlled trials and, 500-501 real world efficacy and, 503 standards for, 500 stepped care and, 504 traditional psychoanalytic treatment and, 505 treatment manuals and, 502 Tricyclic antidepressants anxiety disorders and, 152 depression and, 241-243 S14 Subject Index Trisomy 21, 447 Tryptophan, 225-226 Tunnel vision, 173 Twelve steps of Alcoholics Anonymous, 307 Twin method, behavior genetics and, 108 Two-factor model, post-traumatic stress disorder and, 143 Type A personality anger and hostility reduction and, 209 cardiovascular disorders and, 194,196-197 gender and, 205 U Unconditional positive regard, 492 Unconditioned response, 22 Unconditioned stimulus, 22 Unconscious evidence for, 176 psychoanalysis and, 17 role of, 41-42 Uncued panic attacks, 123 Undifferentiated schizophrenia, 327 United States v. Charters (1987), 537-538 Unjustified polypharmacy 537 Unnecessary surgeries, conversion disorder and, 175 Unresolved grief, 43 Vaginal plethysmograph, 391 Vaginismus, 389 Validity, diagnosis and assessment and, 60-62 Vardenafil, 395 Vascular dementia, 470 Ventricles brain anatomy and, 37 enlarged, 335 Viagra, 395 Vineland Adaptive Behavior Scales, 445 Virtual reality technology, 150 Vocational rehabilitation, schizophrenia and, 350-351 Vouchers, drag dependence and, 313 Voyeurism, 405 W Waxy flexibility, 325 Wechsler Adult Intelligence Scale, 4th edition (WAIS-IV), 84 Wechsler Intelligence Scale for Children, 4th edition (WISC-IV), 84 Wechsler Preschool and Primary Scale of Intelligence (WPPSI-III), 84 Wellbutrin, 395 White matter, 36 Witches, persecution of, 10 Women s Health Initiative (WHI), 205 Working alliance, 512 World Health Organization (WHO) classification system, 64 Worry, generalized anxiety disorder and, 140 Wyatt v. Stickney (1972), 535-536 Yates legal case, 526 Youngberg v. Romeo (1982), 536 Zyprexa, 244, 344-345
adam_txt	Subject Index ABAB design, 114 Acamprosate, 310 Accidents, childhood, 448 Acetylcholinesterase inhibitors, 471 Acquired immunodeficiency syndrome (AIDS), 200-203 clinical description of, 201 disease spreading and, 201 intravenous drug use and, 291 prevention efforts and, 201-203 scope of, 200-201 Acute stress disorder (ASD), 127, 151 Addiction. See Substance-related disorders Addington v. Texas (1979), 533 Adolescent anxiety. See Childhood and adolescent anxiety Adolescent depression. See Childhood and adolescent depression Advanced directives, patient rights and, 538 Advocacy groups, 5 African-Americans, therapeutic considerations and, 508-511 Age. See also specific age group arrest rates and, 427 depressive disorders and, 218-219 dissociative identity disorders and, 166-167 mental retardation and, 445 research methods in study of, 465 Agonists, 36 Agoraphobia cognitive factors in, 139 criteria for, 124 fear-of-fear hypothesis and, 139 psychological treatment of, 147-148 AIDS. See Acquired immunodeficiency syndrome Alaskan Natives, therapeutic considerations and, 511 Alcohol abuse and dependence, 280-283 Alcoholics Anonymous and, 306-307 behavioral treatments and, 307-308 cognitive treatments and, 307-308 couples therapy and, 307 cultural attitudes and, 302-303 delirium tremens and, 280 detoxification and, 305-306 expectancies about, 301-302 fetal alcohol syndrome and, 283 genetic factors and, 296 inpatient hospital treatment and, 305-306 late life and, 483 long-term alcohol effects, 282-283 medications and, 309-310 moderation in drinking and, 309 polydrug abuse and, 280 prevalence and cost of, 281 relapse prevention and, 308 short-term alcohol effects, 282 stress and, 300 treatment of, 305-310 Alcoholics Anonymous (AA), 306-307 Alíeles, 31 Allostatic load, stress hormones and, 189 Alogia, schizophrenia and, 323 Alternate-form reliability, 60 Alternative living settings, older adults and, 487-488 Altruistic suicide, 249 Alzheimer's disease, 108-109, 468-470 Ambulatory monitoring studies, hypertension and, 193-194 Amenorrhea, anorexia nervosa and, 254 American Association on Intellectual and Development Disabilities (AAIDD), 445-447 American Indians, therapeutic considerations and, 511 American Law Institute Guidelines, 521 American Legacy Foundation, 317 Americans with Disabilities Act (ADA), 4, 351 Amok, 67 Amphetamine psychosis, 332 Amphetamines, 291-293 Amygdala, 37, 226-227 Anal stage, psychosexual development and, 19 Analogue experiments, 113-114 Analytical psychology, 20 Anesthesia, conversion disorder and, 173 Angel dust, 296 Anger coronary heart disease and, 197 hypertension and, 194, 209 reducing, 209 Anger-in theory, 191 Angina pectoris, 195 Anhedonia, 323 Anomie suicide, 249 Anorexia nervosa clinical description of, 254-256 cognitive behavioral views and, 264-265 cross-cultural studies and, 268-269 genetic factors, 261-262 medications and, 273 neurobiological factors and, 262-263 perfectionism and, 270 personality influences and, 270-271 physical consequences of, 256 prognosis and, 256 psychodynamic views and, 263-264 psychological treatment of, 273 sociocultural factors and, 266-270 treatment of, 272-276 types of, 254-255 Anosmia, 173 Antabuse, 309 Antagonists, 36 Anterior cingulate, 37, 140 Anticipatory pleasure, schizophrenia and, 323 Anticonvulsant medications bipolar disorder and, 244 depression and, 241 Antidepressant medications anxiety disorders and, 152 bipolar disorder and, 244 childhood and adolescent depression and, 434, 436 depressive disorders and, 241-243 eating disorders and, 272 older adults and, 480-481 Antiobesity medications, 273 Antipsychotic medications bipolar disorder and, 244 depression and, 241 first-generation, 342-344 second-generation, 344-345 Antisocial acts, psychopathy and, 369-370 Antisocial personality disorder, 367-371 clinical description and, 368 etiology of, 368-371 family environment and, 369 genetic factors and, 369 social factors and, 369 Anxiety disorders. See also Childhood and adolescent anxiety; Phobias actual threats and, 132 affective dimensions in, 232 attention to threat and, 133 behavioral inhibition and, 132 characteristics of, 120 clinical descriptions of, 121-127 cognitive factors and, 132-133 common risk factors and, 130-134 commonalties across psychological treatments, 146 comorbidity in, 128 conduct disorder and, 427 critical incident stress debriefing and, 151 defense mechanisms and, 131 etiology of, 134-145 eye movement desensitization and reprocessing and, 150 fear circuit and, 131 S2 Subject Index Anxiety disorders (cont.) gender and, 128-129 genetic factors and, 131 late life, 481-482 medications and, 152-153 negative cognition and, 133-134 neurobiological factors and, 131-132 neuroticism and, 132 perceived control and, 133 personality and, 132 phobias, 121-123 psychoanalytic perspective and, 131 safety behaviors and, 132-133 social environment and, 132 sociocultural factors and, 129-130 treatment of, 145-153 Anxiety reduction, sexual dysfunctions and, 392-394 Anxiety Sensitivity Index, 139 Anxiolytics, 152 Anxious/fearful cluster, personality disorders and, 372-374 Apathy, 323 Aphonia, 173 Aricept, 471 Arousal, post-traumatic stress disorder and, 127 Articulated Thoughts in Simulated Situations (ATSS), 87 Asian-Americans, therapeutic considerations and, 508-511 Asociality, schizophrenia and, 324 Asperger's disorder, 451 Assessment of Daily Experience (ADE) scale, 78-79, 185-186 Assisted-living facilities, 487-488 Assisted outpatient treatment, 4 Association studies, molecular genetics and, 109 Asthma, 197-200 biological factors and, 199 clinical description of, 198-199 etiology of, 199-200 negative emotions and, 199-200 respiratory structures and, 198 role of family and, 200 stressful life events and, 199 Asylums, 11-13 Ataque de nervios, 129 Attachment theory, 42 Attention-deficit/hyperactivity disorder (ADHD), 418-428 adolescent behavior and, 422 adults with, 421-422 clinical descriptions of, 418-420 cultural role and, 419 differential diagnosis and, 420 environmental toxins and, 423 etiology of, 422-424 genetic factors and, 422 neurobiological factors and, 422-423 perinatal and prenatal factors and, 423 prevalence of, 421 psychological factors and, 423-424 psychological treatment and, 425-426 stimulant medications and, 424-425 subcategories of, 420 treatment of, 424-426 Attributional style, 235 Attributional Style Questionnaire (ASQ), 235-236 Attributions, depression and, 235 Autistic disorder, 450-459 Asperger's disorder and, 451 behavioral treatment and, 458 clinical descriptions and, 451-455 communication deficits and, 453-454 diagnosis and causes of, 437 drug treatment and, 459 echolalia and, 453 etiology of, 455-457 genetic factors and, 455 high-functioning and, 453, 456 joint attention and, 452 mental retardation and, 451-452 neurological factors and, 455-457 play and, 453 prognosis and, 454-455 pronoun reversal and, 454 repetitive and ritualistic acts and, 454 social and emotional disturbances and, 452-453 theory of mind and, 453 treatment of, 457-459 Autonomie nervous system, 38, 39, 429 Aversion therapy, paraphilias and, 409-410 Aversive conditioning, 24 Avoidance, post-traumatic stress disorder and, 127 Avoidance coping, 186 Avoidant personality disorder, 123, 372 Avolition, schizophrenia and, 323 Awakenings, 325 В Barbiturates, 291 Bedford College Life Events and Difficulties (LEDS), 78-79, 82 Behavior genetics, 30-31. See also Genetics adoptees method and, 108 family method and, 107 genotypes and, 30 index cases and, 107 IQ and, 31 phenotypes and, 30-31 schizophrenia and, 328-330 twin method and, 108 Behavioral and cognitive assessment, 85-87 capturing thought through specific situation, 87 cognitive-style questionnaires, 86 direct observation, 85 self-observation, 85-86 Behavioral factors/therapies, 493-494 alcohol abuse and, 307-308 anxiety disorders and, 132 autism and, 458 behavioral activation therapy, 493-494 couples therapy, 497 depression and, 238-240 gender identity disorder and, 399 historical overview of, 24 influences from, 44-46 mental retardation and, 449 panic disorder and, 138 post-traumatic stress disorder and, 143 self-control and, 494 skills training, 211 somatoform disorders and, 179 specific phobias and, 135-136 Behavioral medicine field, 184 Behaviorism, 22 Benzedrine, 291 Benzodiazepines, 152 Beta blockers, 152 Bing-eating/purging type of anorexia nervosa, 254-255 Binge drinking, 281 Biological approaches, 14-16. See also Neurobiological assessment electroconvulsive therapy, 15 general paresis and syphilis and, 14-15 genetics and, 15 mood disorders and, 241-244 paraphilias and, 410 prefrontal lobotomy 15-16 psychological approaches, 16-24 Biological factors asthma and, 199 sexual dysfunctions and, 390 Bipolar disorders, 219-221. See also Mood disorders bipolar I disorder, 220 bipolar II disorder, 220 brain-imaging studies and, 226-228 case studies and, 102-103 in children, 436 consequences of, 221 cyclothymic disorder, 220 depression in, 236 epidemiology of, 220-221 family-focused treatment and, 240 flight of ideas and, 219 genetic factors and, 223-224 hypomania and, 220 mania and, 219, 236 medications for, 244 mixed episodes and, 219-220 neurobiological factors and, 223-229 neurotransmitters and, 224-226 psychoeducational approaches and, 240 psychological factors and, 236 psychological treatment of, 240 social factors and, 236 subtypes and, 222 Bipolar I disorder, 220 Bipolar II disorder, 220 Black box warnings, 436-437 Blindness. See also Conversion disorder Blindsight, 175 Blood alcohol concentration calculator, 282 Blood pressure. See also Essential hypertension Body dysmorphic disorder anorexia nervosa and, 254 criteria for, 170 eating disorders and, 267 neurobiology of, 177 treatment of, 179 Body mass index (BMI), 258 BOLD signal, fMRI, 89 Borderline personality disorder, 362-365 childhood abuse and, 364 clinical description of, 362-363 dialectical behavior therapy and, 377-378 diathesis-stress theory and, 364365 etiology of, 363-365 Subject Index S3 neurobiological factors and, 363-364 object relations psychotherapy and, 377 object relations theory and, 364 psychotherapy efficacy and, 378-379 schema-schema-focused cognitive therapy and, 378 social factors and, 364 treatment of, 376-379 Brain. See Neurobiological assessment/factors Brain imaging, 89-90, 226-228 Brain stem, 37 Brain structure and function, 36-38 Breast self-examination, 210-211 Brief psychotic disorder, 327 Brief therapy, psychodynamic, 43 Briquets syndrome, 171 Bulimia nervosa clinical description of, 256-258 cognitive behavioral views and, 265-266 cross-cultural studies and, 369 genetic factors, 261-262 medications and, 272-273 neurobiological factors and, 262-263 personality influences and, 270-271 physical consequences of, 258 prognosis and, 258 psychodynamic views and, 263-264 psychological treatment and, 274-275 sociocultural factors and, 266-270 subtypes of, 257 treatment of, 272-276 Buprenorphine, 315 Bupropion, 395 С Caffeine, 292 Cancer coping with, 210-211 ethnicity and, 207 interventions and, 210 problem-solving therapy and, 210 Capital punishment issues, 527-530 Cardiovascular disorders coronary heart disease, 195-197 depression and, 479 essential hypertension and, 192-195 ethnicity and, 207 Caregiver support, dementia and, 473 Carpal tunnel syndrome, 174 Case studies, 100-103 advantages and disadvantages of, 102 characteristics of, 100-101 hypotheses and, 101 as rich description, 101 Castration, 410 Castration anxiety 407 Catastrophic misinterpretation, 130 Catatonia catatonic immobility, 325 mood disorders and, 222 schizophrenia and, 325, 327 Categorical classification, 70-71 Cathartic method, 17 Causality problems, correlational method and, 105 Celexa, 242 Cerebellum, 37, 337 Cerebral blood flow, schizophrenia and, 336 Change research, psychotherapy process and, 513-514 Chaos theory, 99 Child abuse. See also Sexual abuse borderline personality disorder and, 364 dissociative identity disorder and, 163 eating disorders and, 271 memory repression and, 158-159 paraphilias and, 408 pedophilia and incest, 402-405 Childhood and adolescent anxiety, 438-441 clinical descriptions of, 438-439 cognitive behavior therapy and, 440-441 obsessive compulsive disorder and, 439 prevalence of, 439 school phobia and, 439 social phobia and, 439 treatment of, 440-441 Childhood and adolescent depression, 433-438 antidepressants and, 434 clinical descriptions of, 433 cognitive behavioral treatments and, 435 etiology of, 434-435 prevalence of, 433 prevention and, 438 psychosocial interventions and, 435 psychotherapy and, 438 treatment controversies and, 436-437 treatment of, 434-438 Childhood disorders antidepressant medications controversies, 436 anxiety and, 438-441 attention-deficit/hyperactivity disorder, 418-428 autistic disorder, 437, 450-459 bipolar disorder controversies, 436 classification of, 418 conduct disorder, 426-432 controversies in diagnosis and treatment, 436-437 depression and, 433-438 diagnosis of, 418 externalizing disorders and, 418 internalizing disorders and, 418 learning disabilities, 441-444 mental retardation, 444-450 stimulant medication controversies, 436-437 Chromosomal abnormalities, mental retardation and, 447 Cialis, 395 Cigarette smoking, 284-285. See also Nicotine advertising and media and, 304 prevalence and health consequences of, 284 secondhand smoke and, 284-285 Citalopram, 242 Civil commitment, 530-540 advanced directives and, 538 deinstutionalization and, 538-540 least restrictive alternative and, 533-534 outpatient commitment, 532-533 patient's rights protection and, 533-538 prediction of dangerousness and, 532-533 preventative detention and, 531-533 privileged communication and, 534-535 right to refuse treatment, 537-538 right to treatment and, 534-537 Classical conditioning historical overview and, 22 panic disorder and, 138 specific phobias and, 135 Cleanliness, compulsions and, 125 Client-centered therapy, 491-492 Clinical interviews, 74-76 characteristics of, 75 structured interviews, 75-76 Clinical psychologists, 25 Clinical significance, correlational method and, 104-105 Clozapine, 344-345 Cocaine, 293-294, 300, 313, 315 Cocaine vaccine, 315 Cognition distortions, paraphilias and, 408 Cognitive behavior therapy, 47-48. See also Cognitive treatments anorexia nervosa and, 273 Beck's cognitive therapy, 47 bulimia nervosa and, 274-275 childhood and adolescent anxiety and, 440-441 childhood and adolescent depression and, 435 couples and, 497 eating disorders and, 264-266 Ellis's rational-emotive behavior therapy, 47-48 illicit drag abuse and, 312-313 interventions, 212 outcome studies and, 506 paraphilias and, 409-410 personality disorders and, 375-376 schizophrenia and, 349-350 somatoform disorders and, 177-178 Cognitive behavioral paradigm behavior therapy influences, 44-46 cognitive behavior therapy, 47-48 cognitive science, 46-47 evaluating, 48 psychodynamic paradigm compared, 48 Cognitive biases, depression and, 233 Cognitive disorders, late life, 467-475 Cognitive enhancement therapy, 349-350 Cognitive factors. See also Social- cognitive perspective agoraphobia and, 130 anxiety disorders and, 132-133 depression and, 233-236 generalized anxiety disorder and, 140 obsessive-compulsive disorder and, 141-142 panic disorder and, 138-139 social phobias and, 137 stress and, 191 Cognitive functioning late life and, 463-464 marijuana use and, 286 S4 Subject Index Cognitive restructuring, 47, 211 Cognitive science, 46-47 Cognitive-style questionnaires, 86 Cognitive treatments, 494-495. See also Cognitive behavior therapy; Social-cognitive perspective alcohol abuse and, 307-308 depression and, 238-239 mental retardation and, 449 somatoform disorders and, 179 Cohort effects, research studies and, 465 Collective unconscious, 20 Common factors research, 512-513 Communication deficits, autistic disorder and, 453-454 Communication deviance, 338 Communication training, sexual dysfunctions and, 394 Community psychology, 514-515 Community-reinforcement approach, 307 Competency to stand trial, 524-527 Compulsions, 125 Computer-assisted instruction, mental retardation and, 449-450 Computerized axial tomography (CT scan), 89 Concordance, 108 Concurrent validity, 60 Conditioned response, 22 Conditioned stimulus, 22 Conditioning social phobias and, 136-137 specific phobias and, 135-136 Conduct disorder, 426-432 autonomie nervous system and, 429 clinical description and, 427 Dodge's aggression theory and, 430 etiology of, 428-430 family interventions and, 430-431 genetic factors and, 428-429 life-course-persistent type, 427-428 modeling and, 429 multisystemic treatment and, 432 neuropsychological factors and, 429 peer influences and, 430 prevalence of, 427 prognosis and, 426-427 psychological factors and, 429-430 social-cognitive perspective and, 429-430 sociocultural factors and, 430 treatment of, 430-432 Confidentiality, 543 Congenital factors, schizophrenia and, 336-337 Consensus Project, 540 Construct validity, 61, 72 Consummatory pleasure, 323 Contemporary psychodynamic perspectives, 43-44 Contemporary thought, 14-19 Content validity, 60 Contingency management therapy, 307 Continuing care retirement communities, 488 Control groups, 111 Controlled drinking, 309 Conversion disorder, 173-177 anesthesia and, 173 blindsight and, 175 cultural factors and, 175-176 description of, 168 diagnostic rates and, 176-177 etiology of, 174-177 psychodynamic perspective and, 175 social factors and, 175-176 symptoms of, 173-174 treatment of, 181 Coping avoidance copying, 186 emotion-focused, 186 health and, 186-187 problem-focused, 186 Coping Orientations to Problems Experienced Scale (COPE), 186-187 Coronary Artery Risk Development in Young Adults Study (CARDIA), 194 Coronary heart disease angina pectoris, 195 clinical description of, 195 etiology of, 195-196 gender and, 205 metabolic syndrome and, 195 myocardial infarction and, 195 psychological risk factors and, 196-197 stress and myocardial infarction, 196 Corpus callosum, 36 Correlation coefficient, 104 Correlational method, 101-109 behavior and molecular genetics example, 107-109 causality problems and, 105 clinical significance and, 104-105 correlation coefficient, 104 cross-sectional design and, 105 differences from experimental research, 101-103 directionality problem and, 105 epidemiological research example, 106-107 examples of, 103-104 high-risk method and, 106 longitudinal design and, 105 measuring correlation, 104 scatter diagrams and, 105 statistical significance and, 104 third-variable problems and, 106 Cortisol depression and, 228-229 post-traumatic stress disorder and, 143 release of, 38 Counseling psychologists, 26 Couples therapy, 495-496 alcohol abuse and, 307 depression and, 240 outcome studies and, 506-507 sexual dysfunctions and, 394 Crack, 293-294 Creativity, mood disorders and, 221 Criminal commitment, 518-530 in absentia trials and, 525 capital punishment issues, 527-530 competency to stand trial and, 524-527 dissociative identity disorder and, 528 insanity defense and, 519-524 mental retardation and, 530 synthetic sanity concept and, 527 Criterion validity, 60 Critical incident stress debriefing, 151 Cross-dependent narcotics, 314 Cross-dressing, 401-402 Cross-fostering, 108 Cross-sectional design, correlational method and, 105 Cultural factors. See Sociocultural factors Cushing's syndrome, 228-229 Cyclothymic disorder, 220 Cytokines, stress and, 190-191 D D-cycloserine, 152 Dahmer legal case, 523 DARE project, 316 Dark Ages, 9-11 Decnminalization, 4 Defense mechanisms, 18 Deinstutionalization, 13, 538-540 Delirium, late life, 474-475 Delirium tremens (DTs), 280 Delusional disorders/delusions bipolar disorders and, 222 key features and, 327 late life, 482 schizophrenia and, 321-322 Demand-withdraw cycle, 496 Dementia, 467-473 Alzheimer's disease, 468-470 caregiver support and, 473 caused by disease and injury, 471 versus depression, 478-479 frontotemporal, 470 with Lewy bodies, 470-471 medications and prevention, 471-472 psychological treatments, 472 treatment of, 471 vascular, 470 Dementia praecox, 326 Demonology, 8—11 Depakote, 244 Dependent personality disorder, 372-373 Dependent variables, experiments and, 110 Depersonalization, panic attacks and, 123 Depersonalization disorder, 160-161 Depression, 215-219. See also Childhood and adolescent depression; Mood disorders; Suicide affect and neuroticism and, 232 age and, 218-219 Alzheimer's disease and, 471 avoidant personality disorder and, 372 Beck's theory and, 233-234 behavioral activation and, 238-239 behavioral couples therapy and, 240 bipolar disorder and, 236 brain-imaging studies and, 226-228 cardiovascular disease and, 479 childhood, 433-438 co-morbidity and, 219 cognitive theories and, 233-236 cognitive therapy and, 238—239 conduct disorder and, 427 consequences of, 218 Cortisol dysregulation and, 228-229 Subject Index S5 versus dementia, 478-479 dysthymic disorder, 216-219 electroconvulsive therapy and, 241 epidemiology of, 217-218 expressed emotion and, 230 Freud's theory and, 231-232 gender factors and, 217 genetic factors and, 223-224 hopelessness theory and, 234-236 interpersonal difficulties and, 230-231 interpersonal psychotherapy and, 237-238 late life, 478-481 life events and, 230-231 major depressive disorder, 216-219 MDD treatment comparison, 243-244 medications for, 241-243 mindfulness-based therapy and, 239 negative self-concept and, 231 neurobiological factors and, 223-229 neurotransmitters and, 224-226 primary care and, 245-246 problem-solving skills and, 231 psychological factors in, 231-236 psychological treatment of, 237-240 seasonal affective disorder, 218 sexual dysfunction and, 391 social factors and, 230-231 social support and, 230 subclinical depression, 216 subtypes of, 222 symptoms of, 215-216 Derailment, schizophrenia and, 324 Derealization, panic attacks and, 123 Desipramine, 313 Desire phase, sexual response cycle, 384 Detoxification, 305-306, 312 Developmental factors, schizophrenia and, 336-337, 340-341 Developmental psychopathology, 418. See also Childhood disorders Dexedrine, 291 Dhat, 67 Diagnosis and assessment. See also assessment types Bedford College Life Events and Difficulties Schedule, 78-79 behavioral and cognitive assessment, 85-88 brain imaging, 89-90 clinical interviews, 74-76 cognitive-style questionnaires, 86 cultural bias and, 94-96 daily experience assessment, 78 direct observation of behavior, 85 general criticisms of, 73 intelligence tests, 84-85 neuropsychological assessment, 91-92 neurotransmitter assessment, 90-91 personality tests, 79-83 projective personality tests, 82-83 psychophysiological assessment, 92-93 reliability and, 59-60 self-observation, 85-86 self-report personality inventories, 79-82 social readjustment rating scale, 76 stress assessment, 76-79 structured interviews, 75 validity and, 60-62 Diagnostic and Statistical Manual oj Mental Disorders (DSM-IV-TR), 62-73 categorical vs. continuum diagnoses, 70-71 categories in need of further study, 67 category validity and, 71-73 defining mental disorders and, 4-7 ethnic and cultural considerations and, 65-69 history of, 64 improvements in, 64-65 multiaxial classification system, 62-63 number of diagnostic categories, 65,70 possible changes for DSM-Y 73 reliability of, 71 specific criticisms of, 70-73 Dialectical behavior therapy, 377-378 Diathesis-stress paradigm, 53-55, 364-365 Diet fads, 267 Dietary-depressive subtypes, 257 Dietary restraint scale, 263 Direct observation of behavior, 85 Directed masturbation, 394 Directionality problem, correlational method and, 105 Disability, defining mental illness and, 5-6 Discrimination, health problems and, 206 Discriminatory laws, 4 Disorganized schizophrenia, 324-325, 327 Disorientation, Alzheimer's disease and, 468 Dissociation and memory, 157 Dissociative disorders definition of, 157 depersonalization disorder and, 160-161 dissociative amnesia, 158-159 dissociative fugue, 160 dissociative identity disorder, 161-167 explicit memory and, 158-159 implicit memory and, 159 post-traumatic stress disorder and, 143-144 stress and, 157 Dissociative fugue, 160 Dissociative identity disorder, 161-167 age regression and, 166-167 childhood abuse and, 163 clinical description of, 161-163 clinician detection patterns and, 165 emergence after treatment starts, 165 epidemiology of, 162-163 etiology of, 163-164 handwriting samples and, 166 hypnosis and, 166-167 implicit memory and, 165 insanity defense and, 528 posttraumatic model and, 163 psychodynamic treatment and, 166 role-playing and, 164-165 sociocognitive model and, 163 treatment of, 166-167 Divalproex sodium, 244 Dizygotic (DZ) twins, 108 DNA transcription, 31-32 Donepezil, 471 Dopamine eating behavior and, 263 mood disorders and, 224-225 psychopathology and, 35 schizophrenia and, 332-334 Dot probe task, 134 Double-blind procedures, 112 Down syndrome, 108-109, 447 Dramatic/erratic cluster, personality disorders and, 362-371 Drug abuse. See Substance-related disorders Drug-rehabilitation homes, 313-314 Drug replacement treatment and medications, 314-316 DTNBP1 gene, 331 Dual allegiance, 544 Dysfunction, defining mental illness and, 7 Dysfunctional Attitudes Scale (DAS), 86, 233 Dyslexia, 442-443 Dyspareunia, 389 Dysthymic disorder, 216-219. See also Depression Eating disorders anorexia nervosa, 254-256 binge eating disorder, 259-260, 275 bulimia nervosa, 256-258 child abuse and, 271 cognitive behavioral views, 264-266 cross-cultural studies and, 268-269 ethnic differences and, 269-270 family characteristics and, 271 gender influences and, 267-268 genetic factors and, 261-262 medications and, 272-273 neurobiological factors and, 262-263 obesity and, 259-260 personality influences and, 270-271 preventative interventions for, 276 psychodynamic views and, 263-264 psychoeducational approaches and, 276 psychological treatment of, 273-275 risk factor approach and, 276 sociocultural factors and, 52, 266-270, 276 treatment of, 272-276 Eating Disorders Inventory, 254-255 Echolalia, 453 Ecological momentary assessment, 86 Ecstasy, 295-296 Education and training, 5 Effectiveness, treatments. See Treatment outcome research Ego, 17-18 Ego analysis, 21 S6 Subject Index Ego-dystonic homosexuality, 383 Egoistic suicide, 248-249 Electrocardiograms (EKG), 92 Electroconvulsive therapy (ЕСТ), 15,241,480 Electrodermal responding, 92 Electroencephalograms (EEG), 93 Emotion-focused coping, 186 Emotion-focused therapy, 492 Emotional components, psychopathy and, 369-370 Emotional disturbances, autism and, 452-453 Emotionally focused couples therapy, 497 Emotions, psychopathology and, 49-50 Empathy, 491 Empirically supported treatments, 500 Employment, 4 Empty-chair technique, 492 Encephalitis, 471 Endogenous opioids, eating disorders and, 262 Enhancement therapy, 313 Enhancing Recovery in Coronary Heart Disease (ENRICHD), 209 Enlarged ventricles, schizophrenia and, 335 Entactogens, 295 Environmental-change approaches, stress and, 211-212 Environmental hazards, mental retardation and, 448 Environmental toxins, attention- deficit/hyperactivity disorder and, 423 Episodic disorder, 216 Erectile dysfunction, 388, 395 Essential hypertension, 192-195 angry thoughts and, 194, 209 cardiovascular reactivity and, 194-195 clinical description of, 193 etiology of, 193 exercise and, 209 stress and, 187-188, 193-194 treatment of, 208-209 type A behavior pattern and, 194 Ethical dilemmas, 541-544 confidentiality and, 543 dual allegiance and, 544 informed consent and, 542-543 privileged communication and, 543 research restraints and, 541-542 Ethnicity assessment and, 94-96 cancer and, 207 cardiovascular disease and, 207 DSM-1V-TR and, 65-69 eating disorders and, 269-270 health and, 207 prevalence rates and, 52 psychological treatments and, 508-510 Excitement phase, sexual response cycle, 384 Exelon, 471 Exercise exercise-induced asthma, 199 hypertension and, 209 memory problems and, 472 Exhibitionism, 405-406 Exorcism, 9 Expectancies, alcohol and drug effects and, 301-302 Experiential therapies, 491-492 client-centered therapy, 491-492 emotion-focused therapy, 492 Gestalt therapy, 492 outcome studies and, 505-506 Experiments, 110-115 analogue experiments, 113-114 basic features of, 110 control groups and, 111 dependent variables and, 110 experimental effect, 110 external validity and, 111-113 independent variables and, 110 internal validity and, 110-111 placebos and, 111 random assignment and, 110 single-subject experiments, 114-115 Explicit memory, dissociative amnesia and, 158-159 Exposure and ritual prevention (ERP), 149 Exposure-focused therapy anxiety disorder and, 146 example of, 493 obsessive-compulsive disorder and, 149 phobias and, 146-147 Expressed emotion, 230, 339-340 External validity, experiments and, 111-113 Externalizing disorders, childhood. See also Childhood disorders Extinction, 22 Extrapyramidal side effects, antipsychotic drugs and, 343 Extroversion, depression and, 232 Eye movement desensitization and reprocessing (EMDR), 150 Factitious disorder, 168 Family check up (FCU), 430 Family environment antisocial personality disorder and, 369 asthma and, 200 eating disorders and, 271 psychopathology and, 369 schizophrenia and, 338-340 substance-related disorders and, 303 Family method, behavior genetics and, 107 Family studies, schizophrenia and, 328 Family therapy, 497-498 anorexia nervosa and, 273 bipolar disorder and, 240 bulimia nervosa and, 275 conduct disorder and, 430-431 schizophrenia and, 348-349 Fear circuit, 131 Fear-of-fear hypothesis, 130 Federal Mental Health Parity Act (1996), 4 Feingold's theory, 423 Female orgasmic disorder, 388-389 Female sexual arousal disorder, 388 Fenfluramine, 459 Fetal alcohol syndrome, 283 Fetishism, 401 First-generation antipsychotic drags, 342-344 Five-factor model, 359-360 Fixation, 19 Flashbacks, hallucinogens and, 295 Flat affect, schizophrenia and, 323-324 Flight of ideas, 219 Fluoxetine, 272 Forced medication, criminal commitment and, 527 Forced rape. See Rape Forcible medication, 537-538 Forensic hospitals, 13 Formal thought disorder, 324-325 Fragile X syndrome, 447 Free association, 18 Freedom Center, 5 Friends'Asylum, 12 Frontal lobe, 36 Frontotemporal dementia, 470 Frotteurism, 406 Fugue, dissociative, 160 Functional activation studies, mood disorders and, 226-228 Functional MRI (fMRI), 89 Functional social support, 187-188 G G-proteins, 226 Gamma-aminobutyric acid (GABA), 35 Gender anxiety disorders and, 128-12', body dysmorphic disorder and, 170 coronary heart disease and, 205 depressive disorders and, 217 dieting and, 267 eating disorders and, 267-268 hypertension and, 194 infectious diseases and, 205-206 mortality and morbidity rates and, 204-206 personality disorders and, 357 sexuality and, 382-384 type A behavior and, 205 Gender identity disorder, 396-400 behavior treatment and, 399 clinical description of, 396 genetic factors and, 397 neurobiological factors and, 397 plastic surgery and, 398 psychological factors and, 397-398 sex-reassignment surgery and, 398-399 social factors and, 397-398 Gene-environment interactions, 31-32 Gene expression, 29 General adaptation syndrome, 184-185 General paresis, 14-15 Generalized anxiety disorder, 124-125 cognitive factors and, 140 etiology of, 140 psychological treatment of, 148-149 Genes, 29 Genetic factors Alzheimer's disease and, 469 antisocial personality disorder and, 369 anxiety disorders and, 131 attention-deficit/hyperactivity disorder and, 422 autism and, 455 conduct disorder and, 428-429 gender identity disorder and, 397 mental retardation and, 447 mood disorders and, 223-224 obesity and, 260 psychopathy and, 369 schizophrenia and, 328-332 somatoform disorders and, 177 substance-related disorders and, 298-299 Genetic paradigm, 29-34 behavior genetics, 30-31 evaluating, 33 Subject Index S7 gene-environment interactions, 32-33 molecular genetics, 31-32 reciprocal gene-environment interactions, 33 Genital stage, psychosexual development and, 19 Genome-wide scans, schizophrenia and, 331 Genotypes, 30 Gestalt therapy, 492 Ghost sickness, 67 Glutamate, 334 Grandiose delusions, 322 Gray matter, 36 Group therapy, 13 Guided self-change, 309 Guilty but mentally ill (GBMI), 519,523-524 H Hallucinations bipolar disorders and, 222 schizophrenia and, 322 Hallucinogens, 294-295 Haloperidol, 459 Halstead-Reitanneuropsychological test battery, 91-92 Handwriting samples, dissociative identity disorder and, 166 Harmful dysfunction, 7 Harmful treatments, 501-502 Hashish, 285 Head Start, 431 Health psychology, 184 Heroin, 289-291, 313 Heroin substitutes, 314-315 High-risk method, schizophrenia and, 106 Hikikomori, 52, 68 Hinckley legal case, 521-522 Hippocampus depression and, 226-227 diagram of, 37 hormones and, 142-143 schizophrenia and, 337 History, 8-13 asylum development, 11-13 of classification and diagnosis, 64 Dark Ages, 9-11 demonology, 9-11 early biological explanations, 9 early demonology, 8-9 lunacy trials, 10-11 mental hospitals today, 13 moral treatment, 12-13 persecution of witches, 10 Pinel's reforms, 12 Histrionic personality disorder, 365 Homelessness, 4-5 Homosexuality, historical classification of, 383 Hopelessness theory, depression and, 234-236 Hormonal agents, paraphilias and, 410 Hormone replacement therapy, 204 Hospital funding, 13 Hostility coronary heart disease and, 197 reducing, 209 Hot cognitions, 495 Housing options, 4—5 ΗΡΑ axis, 38, 228-229 Hydrocodone, 289-291 Hypertension. See Essential hypertension Hypnosis, 17, 166-167 Hypnotizability, 53 Hypoactive sexual desire, 387-388 Hypochondriasis, 171, 180 Hypomania, 220 Hypothalamus, 37, 262 Hypotheses, 98, 101 Hysteria, 16, 173 Hysterical blindness, 175 I Ideal affect, 50 Ideas of reference, 322 Illicit drug use. See Substance- related disorders Imaginai exposure, 45, 150 Immobility, catatonic, 325 Immune system components of, 190 stress and, 189-191 Implicit memory dissociative amnesia and, 159 dissociative identity disorder and, 165 Impulse control disorders, 494 Impulsivity, psychopathy and, 370-371 In absentia trials, 525 In vivo (learned) exposure to feared objects, 146 Inappropriate affect, schizophrenia and, 325 Incentive-sensitization theory, 299 Incest, 404-406 Independent variables, experiments and, 110 Index cases, behavior genetics and, 107 Indiana v. Edwards (2008), 527 Individual psychology, 20-21 Infectious diseases gender and, 205-206 mental retardation and, 448 Informed consent, 542-543 Insanity defense, 519-524 American Law Institute guidelines and, 521 dissociative identity disorder and, 528 guilty but mentally ill, 519, 523-524 Insanity Defense Reform Act and, 521-523 irresistible impulse concept and, 520 landmark cases and laws, 520-524 M'Naghten rale and, 520 not guilty by reason of insanity plea, 519 standards of proof and, 523 Insanity Defense Reform Act, 521-523 Insurance coverage, 4 Integrative behavioral couples therapy (ІБСТ), 496 Intellectual functioning, marijuana use and, 286 Intelligence, post-traumatic stress disorder and, 144 Intelligence tests, 31, 84-85, 429, 445 Interdisciplinary health care teamwork, 485 Interleukin-6, 190-191 Internal consistency reliability, 60 Internal validity, experiments and, 110-111 Internalizing disorders, childhood. See also Childhood disorders Interoceptive conditioning, panic disorders and, 138 Interpersonal deficits, 43 Interpersonal relationship importance, 42-43 Interpersonal therapy, 43-44, 237-238 Interpretation, 20 Interrater reliability, 60, 71, 76 Interviews. See Clinical interviews Intravenous drug use, AIDS and, 291 Irresistible impulse concept, 520 Jackson v. Indiana (1972), 526-527 Job strain, myocardial infarction and, 196 Joe Camel, 304 Joint attention, 452 Jones legal case, 523-524 К Kayak-angst, 129 Kelly legal case, 529 Koro, 67, 129 Kyofusho, 129 Kyol goeu, 129 La belle indifference, 168 Lamictal, 244 Lamotrigene, 244 Late life. See also Late life psychological disorders adjusting treatment and, 484 age effects and, 465 alternative living settings and, 487-488 Alzheimer's disease and, 468-470 cognitive disorders in, 467-475 cognitive functioning and, 463-464 cohort effects and, 465 delirium and, 474-475 demarcation points and, 462-463 dementia and, 467-473 dementia with Lewy bodies and, 470-471 frontotemporal dementia and, 470 interdisciplinary health care teamwork, 485 living situations and, 485-488 myths regarding, 463-464 nursing homes and, 486-487 polypharmacy and, 464-465 problems experienced in, 464-465 psychological disorders in, 476-483 research methods and, 465-466 sexual interest and capacity and, 464 sleep quality and, 464 social problems and, 462 social selectivity and, 464 time-of-measurement effects and, 465 vascular dementia and, 470 Late life psychological disorders, 476-483 anxiety disorders, 481-482 delusional (paranoid) disorders, 482 depression vs. dementia, 478-479 etiology of depression, 479-480 major depressive disorder, 478-481 medical issues in diagnosing, 478 prevalence of, 476-478 S8 Subject Index Late life psychological disorders (cont.) substance abuse and dependence, 483 suicide and, 481 treatment of depression, 480-481 Latency period, psychosexual development and, 19 Latinos, therapeutic considerations and, 508-510 Laughing gas, 296 Law of effect, 23 Lead-based paint, 448-449 Lead poisoning, 423 Learned helplessness theory, 234-236 Learning disabilities, 441-444 clinical descriptions and, 442 dyslexia, 442-443 etiology of, 442-444 mathematics disorder and, 443-444 treatment of, 444 Least restrictive alternative, 533-534 Legal issues. See Civil commitment; Criminal commitment; Insanity defense Lessard v. Schmidt (1976), 533 Levitra, 395 Lewy bodies, 470-471 Libido, 17 Life events asthma and, 199 depression and, 230-231 timeline, 79 Limbie system, 37 Linkage analysis, 108-109 Lithium, bipolar disorder and, 244 Live Change Unit (LCU) scale, 76 Living situations, late life, 485-488 Lobotomy, 15-16 Locus ceruleus, panic disorders and, 137-138 Longitudinal design, correlational method and, 105 Loose associations, schizophrenia and, 324 LSD, 294-295 Lunacy trials, 10-11 Luria-Nebraska battery, 92 M Magnetic resonance imaging (MRI), 89 Major depressive disorder (MDD), 216-219, 478-481. See also Depression Male erectile disorder, 388 Male orgasmic disorder, 389 Malingering, 168 Mania bipolar disorder and, 236 criteria and, 219 hypomania, 200 Marijuana, 285-288 historical aspects of, 285-286 physical consequences and, 286-287 psychological effects and, 286 therapeutic effects of, 287-288 use prevalence and, 286 Marriage therapists, 26 Masochism, sexual, 406 Mass media, substance-related disorders and, 303-304 Masturbation, directed, 394 Maternal smoking, 423 Mathematics disorder, 443-444 MATRICS project, 345 Matrix treatment, 316 McArthur Violence Risk Assessment Study, 531 MDA, 295 MDMA, 295 Media influences, substance-related disorders and, 303-304 Medicaid, 13 Medicare, 13 Megan's law, 410 Melancholia, 222 Memantine, 471 Memory. See also Dissociative disorders aids, 472 child abuse and, 158-159 dissociation and, 157 dissociative amnesia and, 159 dissociative identity disorder and, 165 exercise benefits and, 472 explicit, 158-159 implicit, 159 marijuana use and, 287 post-traumatic stress disorder and, 143-144 recovered, 158—159 Meningitis, 471 Mental disorders, definition of, 4-7 Mental health evaluations, 5 Mental health professionals, 25-26 Mental retardation, 444-450 AAIDD approach and, 445-447 accidents and, 448 adaptive functioning and, 445 age of onset and, 445 autism and, 451-452 behavioral treatments and, 449 capital punishment and, 530 chromosomal abnormalities and, 447 cognitive treatments and, 449 computer-assisted instruction and, 449-450 Down syndrome and, 447 DSM-IV-TR categories of, 445 environmental hazards and, 448 etiology of, 447-448 fragile x syndrome and, 447 genetic abnormalities and, 447 infectious diseases and, 448 intelligence test scores and, 444-445 levels of, 445 recessive-gene diseases and, 448 residential treatment and, 449 treatment of, 449-450 Mescaline, 295 Meta-analysis, 116-117 Metabolite studies, 90 Methadone, 314-315 Methamphetamine, 293, 315-316 Methedrine, 291 Methylphenidate, 424-425 Miami Vice, 304 Mind Freedom International, 5 Mindfullness-based cognitive therapy, 239 Minnesota Multiphasic Personality Inventory (MMPI), 79-82 Minority populations, treatment outcomes and, 508-510 Mixed manic episodes, 219-220 M'Naghten rule, 520 Modeling, 23-24 Molecular genetics alíeles and, 31 association studies and, 109 DNA transcription and, 31-32 linkage analysis and, 108-109 polymorphism and, 31 schizophrenia and, 330-331 Monoamine oxidase (MAO) inhibitors, 241-243 Monozygotic (MZ) twins, 108 Mood alteration, substance-related, 300-301 Mood disorders. See also Bipolar disorders; Depression biological treatment of, 241-244 brain-imaging studies and, 226-228 catatonic features and, 222 cortisol dysregulation and, 228-229 creativity and, 221 episodic disorder, 216 etiology of, 223-236 genetic factors and, 223-224 melancholic features and, 222 neurobiological factors and, 223-229 neurotransmitters and, 224—226 psychological treatment of, 237-241 psychotic features and, 222 rapid cycling and, 222 subtypes and, 222 suicide and, 246-251 treatment of, 237-245 Mood stabilizing medications, 241, 244 Moral awareness, 429 Moral treatment, 12-13 Morphine, 289-291 Mortality, social support and, 187 Motivational interviewing, 313 Mowrers two-factor model, 135 Multiaxial classification system, 62-63 Multiple studies, integrating findings of, 116-117 Multisystemic treatment, 432 Munchausen syndrome, 168 Myocardial infarction, stress and, 195-196 N Naloxone, 310, 315 Naltrexone.310, 315, 459 Namenda, 471 Narcissistic personality disorder, 365-367 etiology of, 366 self-psychology model and, 366 social-cognitive model and, 366-367 National Alliance on Mental Illness, 5 National Comorbidity Survey- Replication study, 260 National Depression Awareness Day, 515 Natural immunity, 190 Negative cognition, anxiety disorders and, 133-134 Negative emotionality, 302 Negative reinforcement, 23 Negative schemata, depression and, 233 Negative self-evaluation, 137 Negative triad, depression and, 233 Neo-Freudian psychodynamic perspectives, 20-21 NEO Personality Inventory, 359 Nerve impulses, 34 Neurobiological assessment, 88-94. See also Biological approaches brain imaging, 89-90 cautionary note regarding, 93 neuropsychological assessment, 91-92 Subject Index neurotransmitter assessment, 90-91 psychophysiological assessment, 92-93 Neurobiological factors anxiety disorders and, 131-132 attention-deficit/hyperactivity disorder and, 422-423 autism and, 455-457 borderline personality disorder and, 363-364 eating disorders and, 262-263 gender identity disorder and, 397 obsessive-compulsive disorder and, 140 panic disorder and, 137-138 paraphilias and, 406-407 post-traumatic stress disorder and, 142-143 schizophrenia and, 334-337 stress and, 189-191 substance-related disorders and, 299-300 suicide and, 247-248 Neurofibrillary tangles, 468-469 Neuroleptic malignant syndrome, 343 Neurologists, 91 Neurons, 34-36, 336 Neuropsychological assessment, 91-92 Neuropsychologists, 91 Neuroscience paradigm, 34-40 evaluating, 40 neuroendocrine system, 38 neurons and neurotransmitters, 34-36 neuroscience treatment approaches, 38-40 structure and function of human brain, 36-38 Neuroscience treatment approaches, 38-40 Neurosis, 131 Neuroticism anxiety disorders and, 132 depression and, 232 Neurotransmitter assessment, 90-91 Neurotransmitters anxiety disorders and, 131-132 functions of, 34-36 schizophrenia and, 332-334 Nicotine gum, 311-312 Nicotine patches, 312 Nicotine use. See also Cigarette smoking attention-deficit/hyperactivity disorder and, 423 dependence and, 310-312 health consequences and, 284-285 nicotine replacement treatments and medications, 311-312 psychological treatments and, 311 replacement treatments and, 311 stress and, 300 Nitrous oxide, 296 Nonpurging type, bulimia nervosa, 257 Nonshared environment, 30 Norepinephrine mood disorders and, 224-225 psychopathology and, 35 Not guilty by reason of insanity plea (N GRI), 519 Numbing of responsiveness, 127 Nuremberg Code, 542 Nursing homes, 486-487 Nuthkavihak, 51 О Obesity, 259-260 Object relations psychotherapy, 377 Object relations theory, 42, 364 Objedification theory, 268 Obsessions, 125 Obsessive compulsive disorder (OCD) anterior cingulate and, 140 childhood and adolescent, 439 cognitive factors and, 141-142 criteria and, 125-126 etiology of, 140-142 neurobiological factors and, 140 orbitofrontal cortex and, 140 psychological treatment of, 149 thought suppression and, 141-142 Obsessive-compulsive personality disorder, 373-374 Occipital lobe, 36 O'Connor v. Donaldson (1975), 536-537 Odd/eccentric cluster, personality disorders and, 360-362 Olanzapme, 244, 344-345 Older adults. See Late life Operant conditioning, 23-24, 135 Opiates, 289-291 abuse and dependence and, 289-290 physical effects and, 290-291 psychological effects and, 290-291 synthetic sedatives, 291 types of, 289 Opium, 289-291 Oppositional defiant disorder (ODD), 426 Oral stage, psychosexual development and, 19 Orbitofrontal cortex, obsessive- compulsive disorder and, 140 Orgasm phase, sexual response cycle, 384 Orgasmic disorders, 388-389 Outpatient commitment, 532-533 Oxycodone, 289-291 Pacific Islanders, therapeutic considerations and, 508-511 Pain disorder psychological factors and, 169 sexual, 389 treatment of, 179 Pain management, 180 Panetti legal case, 529-530 Panic attacks, 123-124 Panic control therapy, 148 Panic disorder, 123-124 Anxiety Sensitivity Index and, 139 behavioral factors and, 138 cognitive factors and, 138-139 cognitive process and, 178 etiology of, 137-139 interoceptive conditioning and, 138 neurobiological factors and, 137-138 psychological treatment of, 147-148 sexual dysfunction and, 391 Paradigms characteristics of, 28-29 cognitive behavioral paradigm, 44-48 diathesis-stress paradigm, 53-55 emotions and, 49-50 genetic paradigm, 29-34 multiple perspectives and, 55-56 neuroscience paradigm, 34-40 psychodynamic paradigm, 41-44 sociocultural factors and, 51-52 Paranoia, 482 Paranoid personality disorder, 360 Paranoid schizophrenia, 327 Paraphilias, 400-411 aversion therapy and, 409-410 biological treatment and, 410 cognitive behavioral treatment and, 409-410 etiology of, 406-408 exhibitionism, 405-406 fetishism, 401 frotteurism, 406 incest and, 404-406 neurobiological factors and, 406-407 pedophilia, 402-404 prevalence statistics and, 400-401 psychodynamic perspectives and, 407 psychological factors and, 407-408 sexual masochism, 406 sexual sadism, 406 social skills and, 407-408 transvestic fetishism, 401-402 treatments for, 408-410 voyeurism, 405 Parasympathetic nervous system, 39 Parent-child relationships, paraphilias and, 408 Parent management training (PMT), 431 Parent training, attention- deficit/hyperactivity disorder, 425 Parenting behaviors, nongenetic transference and, 32-33 Paresis, 14-15 Parietal lobe, 36 Parkinson's disease, 332, 470-471 Pate v. Robinson (1966), 524-525 Patient rights protection, 533-538 deinstutionalization and, 538-540 least restrictive alternative concept and, 533-534 right to refuse treatment, 537-538 right to treatment, 534-537 Paul Wellstone Mental Health and Addiction Equity Act (2008), 4 Pedophilia, 402-404 Peer influences, conduct disorder and, 430 Peer leadership, substance-related disorders and, 317 Peer-pressure resistance training, 317 Penile plethysmograph, 391 Perceived control, anxiety disorders and, 133 Perception disturbances, schizophrenia and, 322 Perfectionism, anorexia and, 270 Performance fears, sexual, 389 Perinatal factors, attention- deficit/hyperactivity disorder and, 423 S10 Subject Index Personal distress, defining mental illness and, 5-6 Personality disorders antisocial personality disorder, 367-371 anxious/fearful cluster of, 372-374 associated maladaptive cognitions and, 376 avoidant personality disorder, 372 borderline personality disorder, 362-365 classification of, 356-360 cognitive behavioral therapists and, 375-376 comorbidity and, 358-359 day treatment programs and, 375 dependent personality disorder, 372-373 diagnostic reliability and, 356-358 dramatic/erratic cluster of, 362-371 DSM-IV-TR approach and, 356-359 five-factor model and, 359-360 gender and, 357 histrionic personality disorder, 365 medications and, 375 narcissistic personality disorder, 365-367 obsessive-compulsive personality disorder, 373-374 odd/eccentric cluster of, 360-362 paranoid personality disorder, 360 psychodynamic therapy and, 375 psychopathy and, 367-371 schizoid personality disorder, 360-361 schizotypal personality disorder, 361 treatment of, 375-379 Personality factors eating disorders and, 270-271 stress and, 191 substance-related disorders and, 302 Personality inventories, 79-82 Personality tests, 79-83 projective personality tests, 82-83 self-report personality inventories, 79-82 Pervasive developmental disorders (PDDs), 451. See also Asperger's disease; Autistic disorder Phallic stage, psychosexual development and, 19 Phencyclidine (PCP), 295-296 Phenothiazines, 342-344 Phenotypes, 30-31 Phenylketonuria (PKU), 448 Phobias, 121-123 agoraphobia, 124 combining medications with psychological treatment in, 152-153 comorbidity and, 122 definition of, 121 generalized anxiety disorder, 124-125 obsessive-compulsive disorder, 125-126 panic disorder, 123-124 post-traumatic stress disorder, 126-127 psychological treatment of, 146-147 social phobia, 122-123 specific phobia, 121-122 spectrum model of, 123 in vivo exposure and, 146 Physical consequences, marijuana use and, 286-287 Physical effects, opiates and, 290-291 Physician-assisted suicide, 248 Pick's disease, 470 Pineis reforms, 12 Placebo effect, 112 Placebos, experiments and, 111 Plaques, Alzheimer's disease and, 468-469 Plastic surgery, gender identity disorder and, 398 Pleasure principle, 17 Point systems, attention- deficit/hyperactivity disorder, 425 Policy and legislative strategies, 4 Polydrug abuse, alcohol and, 280 Polygenic psychopathology, 29-30 Polymorphism, 31 Polypharmacy 464-465 Positive affect, depression and, 232 Positive reinforcement, 23 Positive symptoms, schizophrenia and, 321-322 Positron emission tomography (PET scan), 89-90 Post-traumatic stress disorder, 126-127 behavioral factors and, 143 childhood sexual abuse and, 404 dissociation and, 143-144 etiology of, 142-145 hippocampus and hormones and, 142-143 imaginai exposure treatment and, 150 intelligence and, 144 memory suppression and, 143-144 neurobiological factors and, 142-143 psychological factors and, 143-144 psychological treatment of, 150-151 social support and, 144 trauma severity and type and, 142 two-factor model and, 143 virtual reality technology and, 150 Postpartum onset, mood disorders and, 222 Posttraumatic model, dissociative identity disorder and, 163 Poverty, 369 Prediction of dangerousness, 532-533 Predictive validity, 60 Prefrontal cortex depression and, 226-227 functions and, 36 schizophrenia and, 331, 335-336 Prefrontal lobotomy 15-16 Premature ejaculation, 389, 391, 394, 395 Prenatal factors, attention- deficit/hyperactivity disorder and, 423 Prepared learning, 136 Preventative detention, 531-533 Prevention centers, suicide, 251 Prevention science projects, 515 Primary care, depression and, 245-246 Private hospitals, 13 Privileged communication, 534-535, 543 Probands, 107 Problem-focused coping, 186 Problem-solving skills, depression and, 231 Problem-solving therapy (PST), 210 Project DARE (Drug Abuse Resistance Education), 316 Projective hypothesis, 82 Projective personality tests, 82-83 Pronoun reversal, 453 Protective acts, compulsions and, 125 Protein kinase C, 228 Prozac, 272 Pruning, 38 Psilocybin, 295 Psyche, 17 Psychiatric nurses, 26 Psychiatrists, 25-26 Psychoactive medications, 26 Psychoanalytic theory, 17-20 defense mechanisms and, 18 ego and, 17-18 free association and, 18 interpretation and, 20 libido and, 17 pleasure principle and, 17 psyche and, 17 psychoanalytic therapy and, 18-19 reality principle and, 18 repression and, 18 structure of mind and, 17-18 superego and, 18 transference and, 20 unconscious and, 17 Psychodynamic paradigm, 41-44 cognitive behavioral paradigm compared, 48 contemporary psychodynamic perspectives, 43-44 evaluating, 44 interpersonal relationships, 42-43 role of unconscious and, 41-42 Psychodynamic perspectives conversion disorder, 175 paraphilias and, 407 stress and, 191 Psychodynamic therapy approaches to, 491 dissociative identity disorder and, 166 eating disorders and, 263-264 insight-oriented couples therapy, 497 outcome studies and, 505 panic disorder and, 147 personality disorders and, 375 somatoform disorders and, 178 Psychoeducational approaches bipolar disorder and, 240 eating disorders and, 276 Psychoimmunology, 189 Psychological approaches, 16-24 Adler and individual psychology, 20-21 behavior therapy, 24 behavioral and cognitive assessment, 85-87 behaviorism, 22-24 Breuer and cathartic method, 17 classical conditioning, 22-23 Subject Index S11 clinical interviews and, 74-76 ego analysis, 21 Freud and psychoanalysis, 17-20 intelligence tests, 84-85 Jung and analytical psychology, 20 Mesmer and Charcot, 16-17 modeling, 23-24 neo-Freudian psychodynamic perspectives, 20-21 operant conditioning, 23-24 personality tests, 79-83 stress assessment, 76-79 Psychological factors attention-deficit/hyperactivity disorder and, 423-424 bipolar disorder and, 236 conduct disorder and, 429-430 depression and, 231-236 gender identity disorder and, 397-398 late life disorders and, 478-483 marijuana use and, 286 opiates and, 290-291 paraphilias and, 407-408 post-traumatic stress disorder and, 143-144 schizophrenia and, 337-340 substance-related disorders and, 300-302 suicide and, 247, 249 Psychological treatment. See also Psychotherapy/psychoanalysis; Treatment outcome research acute stress disorder and, 151 agoraphobia and, 147-148 anorexia nervosa and, 273 attention-deficit/hyperactivity disorder, 425-426 behavioral therapies, 493-494 bmge eating disorder and, 275 bipolar disorder and, 240 bulimia nervosa, 274-275 client-centered therapy, 491-492 cognitive treatment, 494-495 community psychology and, 514-515 couples therapy, 495-496 culture and, 508-510 dementia and, 472 depression and, 237-240 emotion-focused therapy, 492 ethnicity and, 508-509 experiential therapies and, 491-492 family therapy, 497-498 generalized anxiety disorder and, 148-149 Gestalt therapy, 492 illicit drug abuse and dependence and, 312-313 nicotine dependence and, 311 obsessive-compulsive disorder and, 149 panic disorder and, 147-148 phobias and, 146-147 posttraumatic stress disorder, 150-151 psychodynamic treatment, 491 psychotherapy process research, 512-514 rapists and, 413-414 schizophrenia and, 346-351 specific approaches to, 490-498 treatment outcome research and, 499-508 Psychomotor agitation, 216 Psychomotor retardation, 216 Psychomotor skills, marijuana use and, 286 Psychopathology emotions and, 49-50 sociocultural factors and, 51-52 treatment controversies in children, 436-437 Psychopathy, 367-371 clinical description of, 368 emotional components and, 369-370 etiology of, 368-371 family environment and, 369 genetic factors and, 369 impulsivity and, 370-371 poverty and, 369 response modulation and, 370-371 social factors and, 369 treatment of, 379 Psychopathy Checklist-Revised, 368 Psychophysiology, 92-93 Psychosexual development stages, 19 Psychosocial interventions, childhood and adolescent depression and, 435 Psychotherapy process research, 512-514 change research mechanisms and, 513-514 common factors research, 512-513 Psychotherapy/psychoanalysis anxiety disorders and, 131 approaches to, 491 borderline personality disorder and, 377-379 childhood and adolescent depression and, 438 dementia and, 472 depression and, 237-238 interpersonal relationships and, 43-44 mental health professionals and, 25 outcome studies and, 505 schizophrenia and, 346-347 Psychotic features, mood disorders and, 222 Purging type, bulimia nervosa, 257 Q Questionnaires, cognitive-style, 86 R Racial stereotypes, 510 Random assignment experiments, 110 Randomized controlled trials. See Treatment outcome research Rape, 411-414 college students and, 411-412 crime specifics and, 412-413 etiology of, 413 forced rape, 411 legal system and, 414 psychological treatment and, 413-414 statutory rape, 411 Rapid cycling, 222 Rational-emotive behavior therapy, 47-48, 495 Reactivity, 86 Reassurance seeking, excessive, 231 Recessive-gene diseases, 448 Reciprocal gene-environment interactions, 33 Recovered memories, 158-159 Relapse prevention, alcohol abuse and, 308 Relational self, 42 Relaxation therapy, 210-211 Reliability, diagnosis and assessment, 59-60 Repetitive acts, autism and, 454 Repetitive checking, compulsions and, 126 Repression, memory, 158-159 Repressive sexual attitudes, 175 Research approaches, 100-109 case studies, 100-103 correlational method, 101-109 experiments, 110-115 multiple studies and, 116-117 Research restraints, 541-542 Residential treatment drag abuse and, 313-314 mental retardation and, 449 schizophrenia and, 350-351 Residual schizophrenia, 327 Resolution phase, sexual response cycle, 384 Response modulation, psychopathy and, 370-371 Restraint scale, dietary, 263 Restricting type, anorexia nervosa, 254-255 Reuptake, 35 Reversal designs, 114-115 Reward system, brain, 228 Right to refuse treatment, 537-538 Right to treatment, 534-537 Risk factor approach, eating disorders and, 276 Risperidone, 344-345 Ritalin, 424-425 Ritualistic acts, autism and, 454 Rivastigmine, 471 Role disputes, 43 Role-playing, 163 Role transitions, 43 Rorschach Inkblot Test, 83 Sadism, sexual, 406 Safety behaviors, anxiety disorders and, 132-133 Scatter diagrams, 105 Schema, 46 Schema-schema-focused cognitive therapy, 378 Schemata, negative, 233 Schizoid personality disorder, 360-361 Schizophrenia adoption studies and, 329-330 alogia and, 323 anhedonia and, 323 anticipatory pleasure and, 323 asociality and, 324 avolition and, 323 behavior genetics research and, 328-330 brain structure and function and, 334-337 case management and, 350 catatonia and, 325 clinical descriptions of, 321-327 cognitive behavior therapy and, 349 cognitive enhancement therapy and, 349-350 conceptual history of, 326 congenital factors and, 336-337 consummatory pleasure and, 323 current research and, 337 delusions and, 321-322 developmental factors and, 336-337 S12 Subject Index Schizophrenia (cont.) developmental studies and, 340-341 disorganized behavior and, 325 disorganized speech and, 324-325 disorganized symptoms and, 324-325 dopamine theory and, 332-334 in DSM-IV-TR, 326-327 enlarged ventricles and, 335 etiology of, 328-341 expressed emotion and, 339-340 family-related factors and, 338-340 family therapies and, 348-349 first-generation antipsychotic drugs and, 342-344 flat affect and, 323-324 genetic factors and, 328-332 hallucinations and, 322 inappropriate affect and, 325 loose associations and, 324 medications and, 342-346 molecular genetics research and, 330-331 negative symptoms and, 323-324 neurotransmitters and, 332-334 new drag development and, 345 perception disturbances and, 322 positive symptoms and, 321-322 prefrontal cortex and, 335-336 psychoanalytic therapy and, 346-347 psychological stress and, 337-340 psychological treatments and, 346-351 residential treatment and, 350-351 second-generation antipsychotic drags and, 344-345 social skills training and, 348 sociocultural factors and, 52 socioeconomic status and, 337-338 subtypes and, 327 treatment of, 342-352 twin studies and, 329 Schizophreniform disorder, 327 Schizotypal personality disorder, 361 School interventions, attention- deficit/hyperactivity disorder, 425 School phobia, 439 Scientific methods, 98-100 Seasonal affective disorder, 218 Second-generation antipsychotic drugs, 344-345 Second messengers, 36, 226 Secondhand smoke, health consequences of, 284 Sedatives. See Opiates Selective mortality, 466 Selective serotonin reuptake inhibitors (SSRIs) anxiety disorders and, 152 depression and, 241-243 older adults and, 480 Self-actualization, 491 Self-concept, depression and, 231 Self-control, 494 Self-evaluation, negative, 137 Self-monitoring, 85-86 Self-observation, 85-86 Self-psychology model, narcissistic personality disorder and, 366 Self-report personality inventories, 79-82 Sensate focus, 393 Sensory-awareness procedures, sexual dysfunction and, 394 Šeptal area, 37 Serotonin autism and, 459 eating disorders and, 263 mood disorders and, 224-225 psychopathology and, 35 schizophrenia and, 334 Serotonin transporter gene, 32, 236 Sex offenders, treatment programs and, 409 Sex-reassignment surgery, 398-399 Sexual abuse. See also Child abuse; Rape childhood, 402-406 dissociative identity disorder and, 163 paraphilias and, 408 Sexual anatomy, 385 Sexual assault. See Rape Sexual aversion disorder, 387-388 Sexual desire disorders, 387-388 Sexual dysfunctions anxiety reduction and, 392-394 attitudes and thoughts and, 394 biological factors and, 390 clinical descriptions of, 385-389 communication training and, 394 couples therapy and, 394 directed masturbation and, 394 distal and immediate causes of, 390 etiology of, 389-392 Masters and Johnsons therapy for, 393 medications and physical treatments and, 395 orgasmic disorders, 388-389 by phase of response cycle, 387 predictors of, 390 psychosocial factors and, 391-392 sexual arousal disorders, 388 sexual desire disorders, 387-388 sexual pain disorders, 389 sexual skill training and, 394 treatment of, 392-395 Sexual interest and capacity, late life and, 464 Sexual masochism, 406 Sexual orientation, 396 Sexual pain disorders, 389 Sexual response cycle, 384 Sexual sadism, 406 Sexuality gender and, 382-384 homosexuality classification, 383 sexual norms and behavior, 381-382 sexual response cycle and, 384 Shaping, 23 Shared environment, 30 Shenjing shuairuo, 67 Shenkui, 129 Short-term memory, marijuana use and, 287 Sildenafil, 395 Single-subject experiments, 114-115 Skin conductance, 92 Skinner boxes, 23 Sleep quality, late life and, 464 Social anxiety disorder, 122 Social-cognitive perspective conduct disorders and, 429-430 dissociative identity disorder and, 163 narcissistic personality disorder and, 366-367 Social deficits, 43 Social factors antisocial personality disorder and, 369 anxiety disorders and, 132 autism and, 452-453 bipolar disorder and, 236 borderline personality disorder and, 364 depression and, 230-231 gender identity disorder and, 397-398 general health and, 187-188 post-traumatic stress disorder and, 144 psychopathology and, 369 substance-related disorders anc 303 Social phobias behavioral factors and, 136 childhood, 439 cognitive factors and, 137 criteria and, 122-123 etiology of, 136-137 negative self-evaluation and, 13 Social Readjustment Rating Scale (SRRS), 76, 78 Social selection theory, 337-338 Social selectivity, late life, 464 Social skills paraphilias and, 407-408 schizophrenia and, 348 Social workers, 26 Sociocultural factors anxiety disorders and, 129-130 attention-deficit/hyperactivity disorder and, 419 bias and, 94-96 conduct disorder and, 430 considerations in DSM-IV-TR, 65-69 conversion disorder and, 176 cultural competence and, 509-510 diversity and assessment, 94-96 eating disorders and, 266-270, 268-269, 276 general health and, 206-207 psychopathology and, 51-52 schizophrenia and, 337-338 sensitivity and psychological treatment outcomes, 508-510 sexual dysfunction and, 392 somatization disorder and, 172-173 substance-related disorders and, 302-303, 302-304 suicide and, 248 Somatic arousal, depression and, 232 Somatization disorder, 171-173, 180-181 Somatoform disorders behavioral techniques and, 179 body dysmorphic disorder, 170, 179 cognitive behavioral models and, 177-178 cognitive strategies and, 179 conversion disorder, 173-177, 181 definition of, 167 genetic research and, 177 grouping of, 169 hypochondriasis, 171, 180 mechanisms involved in, 177 pain disorder, 169, 179 Subject Index S13 psychodynamic treatment and, 178 related disorders and, 167 somatization disorder, 171-173, 180-181 treatment of, 178-181 Something Gotta Give, 395 Specific immunity, 190 Specific phobias, 121-122 behavioral factors and, 135-136 Mowrer's two-factor model and, 135 prepared learning and, 136 Spectator role, sexual, 389 Speech, disorganized, 324-325 Speech sounds perception tests, 91 Spellbound, 159 Standardization, personality tests and, 79 Stanford-Binet, 5th edition, 84 Star charts, attention- deficit/hyperactivity disorder, 425 Statistical significance, correlational method and, 104 Statutory rape, 411-414 Stepped care, 504 Stigma characteristics of, 2-3 strategic approach to, 4-5 Stimulant medications, 291-294 amphetamines, 291-293 attention-deficit/hyperactivity disorder and, 424-425 children and, 436-437 cocaine, 293-294 Stonewalling, 497 Stress alcohol use and, 300 allostatic load and, 189 assessment of daily experience and, 78-79, 185-186 asthma and, 197-200 Beford College Life Events and Difficulties, 78-79, 82 behavioral skills training and, 211 cardiovascular disorders and, 192-197 characteristics of, 184-188 cognitive perspectives and, 191 cognitive restructuring and, 211 coping and health, 186-187 dissociation and, 157 environmental-change approaches and, 211-212 essential hypertension and, 192-195 general adaptation syndrome and, 184-185 immune system and, 189-191 management of, 210-212 myocardial infarction and, 196 neurobiological perspectives and, 189-191 personality perspectives and, 191 personality tests, 79-83 psychodynamic perspectives and, 191 relaxation training and, 210-211 schizophrenia and, 337-340 sexual dysfunction and, 391 Social Readjustment Rating Scale, 76, 78 social support and health, 187-188 stress-illness link, 188-192 Stroop task, 46-47 Structural social support, 187-188 Structural studies, mood disorders and, 226-228 Structured interviews, 75-77 Subclmical depression, 216 Subgenual anterior cingulate, depression and, 226-227 Suboxone, 315 Substance abuse. See Substance- related disorders Substance Abuse and Crime Prevention Act (SACPA), 314 Substance-related disorders advertising and media and, 303-304 alcohol abuse and dependence, 280-283 beliefs and expectations and, 317 caffeine and, 292 categories of, 279 cocaine and, 293-294 drug-rehabilitation homes and, 313-314 drug replacement treatments and medications, 314-316 ecstasy and, 295-296 etiology of, 297-304 expectancies and, 301-302 genetic factors and, 298-299 hallucinogens and, 294-295 illicit drug abuse and dependence, 312-316 late life, 483 marijuana and, 285-288 mass media messages and, 317 mood alteration and, 300-301 neurobiological factors and, 299-300 nicotine and cigarette smoking, 284-285 nitrous oxide and, 296 opiates and, 289-291 peer leadership and, 317 peer-pressure resistance training and, 317 personality factors and, 302 phencyclidine (PCP) and, 295-296 prevalence of, 278-279 prevention of, 316-317 psychological factors and, 300-302 psychological treatments and, 312-313 social setting and, 303 sociocultural factors and, 302-304 stigma and, 279 stimulants and, 291-294 substance abuse and, 279 substance dependence and, 279 treatment of, 305-310 Subthreshold symptoms, 128 Suicide altruistic suicide, 249 annual deaths due to, 247 anomie suicide, 249 associated mental disorder treatment and, 250 common myths regarding, 247 egoistic suicide, 248-249 in elderly, 481 epidemiology of, 246 models of, 247-249 neurobiological models and, 247-248 physician-assisted, 248 prevention centers, 251 prevention of, 249-250 psychological disorders and, 247 psychological models and, 249 sociocultural models and, 248 treating suicidality directly, 250-251 Superego, 18 Support groups, 5 Susto, 129 Sybi!, 163 Sympathetic nervous system, 39 Synapse, 35 Synthetic sanity concept, 527 Synthetic sedatives, 291 Syphilis, 14-15 Systematic desensitization, 24, 146 Tactile performance tests, 91 Tadafil, 395 Taijin kyofusho, 67-68, 129, 372 Tarasoff legal case, 534-535 Tardive dyskinesia, 343 Tension-reducing properties, nicotine and, 300-301 Test-retest reliability, 60 Thalamus, 37, 337 Thematic Apperception Test (TAT), 82-83 Theories, 98-100 Therapeutic alliance, 512 Thinness ideal, 267 Thinsperation, 267 Third-variable problems, 106 Thorazme, 342-344 Thought broadcasting, 321 Thought insertion, 321 Thought suppression, 141—142 Threats attending to, 132 perceived, 133 Three Faces of Eve, 163 Time-of-measurement effects, 465 Time-outs, 45 Token economy, 45 Transference, 20 Transvestic fetishism, 401-402 Traumatic experiences. See also Post-traumatic stress disorder reexperiencing, 127 sexual dysfunction and, 391 Treatment manuals, 502 Treatment of Adolescent Depression Study (TADS), 436 Treatment outcome research, 499-508 brief psychodynamic treatments and, 505 choosing between therapies and, 507-508 cognitive behavior therapy and, 506 couples therapy and, 506-507 culture and ethnicity and, 508-510 defining samples and, 502-503 effectiveness studies and, 503 empirically supported treatments and, 500 experiential therapies and, 505-506 family therapy and, 507 harmful therapy, 501-502 issues in, 501-504 randomized controlled trials and, 500-501 real world efficacy and, 503 standards for, 500 stepped care and, 504 traditional psychoanalytic treatment and, 505 treatment manuals and, 502 Tricyclic antidepressants anxiety disorders and, 152 depression and, 241-243 S14 Subject Index Trisomy 21, 447 Tryptophan, 225-226 Tunnel vision, 173 Twelve steps of Alcoholics Anonymous, 307 Twin method, behavior genetics and, 108 Two-factor model, post-traumatic stress disorder and, 143 Type A personality anger and hostility reduction and, 209 cardiovascular disorders and, 194,196-197 gender and, 205 U Unconditional positive regard, 492 Unconditioned response, 22 Unconditioned stimulus, 22 Unconscious evidence for, 176 psychoanalysis and, 17 role of, 41-42 Uncued panic attacks, 123 Undifferentiated schizophrenia, 327 United States v. Charters (1987), 537-538 Unjustified polypharmacy 537 Unnecessary surgeries, conversion disorder and, 175 Unresolved grief, 43 Vaginal plethysmograph, 391 Vaginismus, 389 Validity, diagnosis and assessment and, 60-62 Vardenafil, 395 Vascular dementia, 470 Ventricles brain anatomy and, 37 enlarged, 335 Viagra, 395 Vineland Adaptive Behavior Scales, 445 Virtual reality technology, 150 Vocational rehabilitation, schizophrenia and, 350-351 Vouchers, drag dependence and, 313 Voyeurism, 405 W Waxy flexibility, 325 Wechsler Adult Intelligence Scale, 4th edition (WAIS-IV), 84 Wechsler Intelligence Scale for Children, 4th edition (WISC-IV), 84 Wechsler Preschool and Primary Scale of Intelligence (WPPSI-III), 84 Wellbutrin, 395 White matter, 36 Witches, persecution of, 10 Women's Health Initiative (WHI), 205 Working alliance, 512 World Health Organization (WHO) classification system, 64 Worry, generalized anxiety disorder and, 140 Wyatt v. Stickney (1972), 535-536 Yates legal case, 526 Youngberg v. Romeo (1982), 536 Zyprexa, 244, 344-345
any_adam_object	1
any_adam_object_boolean	1
author_GND	(DE-588)102812855X
building	Verbundindex
bvnumber	BV021832727
callnumber-first	R - Medicine
callnumber-label	RC454
callnumber-raw	RC454
callnumber-search	RC454
callnumber-sort	RC 3454
callnumber-subject	RC - Internal Medicine
classification_rvk	CU 1000 CU 3000
ctrlnum	(OCoLC)428065851 (DE-599)BVBBV021832727
dewey-full	616.89
dewey-hundreds	600 - Technology (Applied sciences)
dewey-ones	616 - Diseases
dewey-raw	616.89
dewey-search	616.89
dewey-sort	3616.89
dewey-tens	610 - Medicine and health
discipline	Psychologie Medizin
discipline_str_mv	Psychologie Medizin
edition	11. ed., internat. student version
format	Book
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01872nam a2200481zc 4500</leader><controlfield tag="001">BV021832727</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20100201 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">061129s2010 xxuabd\| \|\|\|\| 00\|\|\| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2005056738</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780470413340</subfield><subfield code="c">alk. paper</subfield><subfield code="9">978-0-470-41334-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)428065851</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV021832727</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-473</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-11</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC454</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.89</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">CU 1000</subfield><subfield code="0">(DE-625)19079:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">CU 3000</subfield><subfield code="0">(DE-625)19104:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Abnormal psychology</subfield><subfield code="c">Ann M. Kring ...</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">11. ed., internat. student version</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Hoboken, NJ</subfield><subfield code="b">Wiley</subfield><subfield code="c">2010</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XXI, 545 S., getr. Zählung</subfield><subfield code="b">Ill., graph. Darst., Kt.</subfield><subfield code="c">29 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Psychopathologie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Psychology, Pathological</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Psychopathology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Mental Disorders</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Psychische Störung</subfield><subfield code="0">(DE-588)4047686-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4151278-9</subfield><subfield code="a">Einführung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Handboeken (vorm)</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Psychische Störung</subfield><subfield code="0">(DE-588)4047686-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="C">b</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kring, Ann M.</subfield><subfield code="d">19XX-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)102812855X</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2=" "><subfield code="u">http://www.loc.gov/catdir/enhancements/fy0645/2005056738-d.html</subfield><subfield code="3">Publisher description</subfield></datafield><datafield tag="856" ind1="4" ind2=" "><subfield code="u">http://www.loc.gov/catdir/enhancements/fy0645/2005056738-t.html</subfield><subfield code="3">Table of contents only</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung UB Bamberg</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015044696&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-015044696</subfield></datafield></record></collection>
genre	(DE-588)4151278-9 Einführung gnd-content Handboeken (vorm) gtt
genre_facet	Einführung Handboeken (vorm)
id	DE-604.BV021832727
illustrated	Illustrated
index_date	2024-07-02T15:57:47Z
indexdate	2024-07-09T20:45:40Z
institution	BVB
isbn	9780470413340
language	English
lccn	2005056738
oai_aleph_id	oai:aleph.bib-bvb.de:BVB01-015044696
oclc_num	428065851
open_access_boolean
owner	DE-473 DE-BY-UBG DE-355 DE-BY-UBR DE-11
owner_facet	DE-473 DE-BY-UBG DE-355 DE-BY-UBR DE-11
physical	XXI, 545 S., getr. Zählung Ill., graph. Darst., Kt. 29 cm
publishDate	2010
publishDateSearch	2010
publishDateSort	2010
publisher	Wiley
record_format	marc
spelling	Abnormal psychology Ann M. Kring ... 11. ed., internat. student version Hoboken, NJ Wiley 2010 XXI, 545 S., getr. Zählung Ill., graph. Darst., Kt. 29 cm txt rdacontent n rdamedia nc rdacarrier Psychopathologie gtt Psychology, Pathological Psychopathology Mental Disorders Psychische Störung (DE-588)4047686-8 gnd rswk-swf (DE-588)4151278-9 Einführung gnd-content Handboeken (vorm) gtt Psychische Störung (DE-588)4047686-8 s b DE-604 Kring, Ann M. 19XX- Sonstige (DE-588)102812855X oth http://www.loc.gov/catdir/enhancements/fy0645/2005056738-d.html Publisher description http://www.loc.gov/catdir/enhancements/fy0645/2005056738-t.html Table of contents only Digitalisierung UB Bamberg application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015044696&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis
spellingShingle	Abnormal psychology Psychopathologie gtt Psychology, Pathological Psychopathology Mental Disorders Psychische Störung (DE-588)4047686-8 gnd
subject_GND	(DE-588)4047686-8 (DE-588)4151278-9
title	Abnormal psychology
title_auth	Abnormal psychology
title_exact_search	Abnormal psychology
title_exact_search_txtP	Abnormal psychology
title_full	Abnormal psychology Ann M. Kring ...
title_fullStr	Abnormal psychology Ann M. Kring ...
title_full_unstemmed	Abnormal psychology Ann M. Kring ...
title_short	Abnormal psychology
title_sort	abnormal psychology
topic	Psychopathologie gtt Psychology, Pathological Psychopathology Mental Disorders Psychische Störung (DE-588)4047686-8 gnd
topic_facet	Psychopathologie Psychology, Pathological Psychopathology Mental Disorders Psychische Störung Einführung Handboeken (vorm)
url	http://www.loc.gov/catdir/enhancements/fy0645/2005056738-d.html http://www.loc.gov/catdir/enhancements/fy0645/2005056738-t.html http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015044696&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA
work_keys_str_mv	AT kringannm abnormalpsychology

Holdings

There is no print copy available.

Interlibrary loan Place Request Caution: Not in THWS collection! Indexes

MARC

Record in the Search Index

There is no print copy available.

Similar Items